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ABSTRACT
Anthraquinone (AQ) derivatives with relatively high reduction potentials have been
synthesized to afford good candidates for electron transfer studies in DNA. Electron
withdrawing groups on the anthraquinone ring gave derivatives with less negative reduction
potentials. The anthraquinone imide (AQI) derivatives had reduction potentials less negative
than AQ derivatives. The AQI ring system was subject to base-induced hydrolysis.
Water-soluble sulfonated tetraarylporphyrins have been studied in a wide variety of
contexts. Herein, we report the first synthesis of a pentasulfonated porphyrin bearing an internal
cyclic sulfone ring. Treatment of 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrin (TPPS4) with
fuming H2SO4 gave a structure consistent with initial sulfonation followed by dehydration to
give a sulfone bridge between an ortho-position of one of the phenyl groups and a β-pyrrole
position on the porphine ring (TPPS4Sc). The structure was established by ESI-MS and 1HNMR.
The Soret absorption is red shifted by about 32 nm compared to that of TPPS4.

Streptococcus pyogenes obtains iron by taking up heme from the environment during
infection. One of the heme uptake pathways is the Sia or Hts pathway. The initial protein in this
pathway is Shr, which has two heme-binding NEAT domains, NEAT1 nearer the N-terminus,
and NEAT2 nearer the C-terminus. We report biophysical characteristics of these two NEAT
domains. To assess stability of this domain towards heme release, denaturation studies of the
Fe(II) and Fe(III) forms were performed. For each domain, both the Fe(II) and the Fe(III) forms
behave similarly in thermal denaturation and guanidinium denaturation. Overall, NEAT2 is
more stable than NEAT1. Spectral signatures, sequence alignment and homology modeling for
both domains suggest that one of the axial ligands is methionine. NEAT2 autoreduces as the pH
increases and autooxidizes as the pH decreases. Heme uptake from the host environment is the
only iron acquisition pathway in S. pyogenes; inhibition of this pathway might be an approach to
infection control. Compounds that might inhibit the heme uptake pathway were selected via
virtual screening.

INDEX WORDS: Anthraquinone imide, DNA, Electron transfer, Cyclic sulfone, Water-soluble
porphyrin, Red shift, Streptococcus pyogenes, Shr, NEAT, Thermal denaturation, Guanidinium
denaturation, Ligand, Virtual screening.
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1

1.1

Synthesis of anthraquinone derivatives.

Introduction.

1.1.1 Synthesis of anthraquinone/DNA complexes.

Anthraquinones (AQs) have been widely studied as electron acceptors in complexes with
DNA (Armitage et al., 1994; Gasper & Schuster, 1997; Schuster, 2000; Giese, 2000). In these
studies, AQ interacts with oligonucleotide in three different ways: via noncovalent interaction,
via covalent attachment to a base, or via covalent attachment to the sugar of a deoxynucleotide.
In experiments which do not involve covalent attachment, AQ is modified with positively
charged groups and mixed with DNA duplex in solution (Armitage et al., 1994; Breslin et al.,
1997b; Schuster, 2000). In these cases, the AQ derivatives generally intercalate into the DNA
strands or bind in the minor groove.
AQ can be covalently linked to bases (Okamoto et al., 2004; Di Giusto et al., 2004;
Abou-Elkhair & Netzel, 2005a; Tanabe et al., 2006; Okamoto et al., 2006; Gorodetsky et al.,
2007). Di Giusto et al. has covalently attached AQ to cytidine via a 5-atom amine linker before
DNA synthesis (Di Giusto et al., 2004). This amine linker was achieved by a reaction of a
cytidine amide derivative [5-(trans-3-aminopropen-1-yl)deoxycytidine 5’-triphosphate] and 2anthraquinonecarboxylic acid using a condensing reagent [O-(7-azabenzotriazol-1-yl)N,N,N’,N’-tetramethyluronium hexafluorophosphate] in DMSO. The product was purified via a
DEAE-cellulose column to obtain AQ modified dCTP which was used in polymerase-mediated
single base extension assays.
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Adenosine has been attached to AQ with both ethynyl and ethylenyl linkers (Tierney &
Grinstaff, 2000; Abou-Elkhair & Netzel, 2005b). For the ethynyl linker, a protecting group on
the 5’- O of deoxyadenosine, 4,4’-dimethoxytrityl, was used. This linker was prepared by Pd(0)
[tetrakis(triphenylphosphine) palladium] catalyzed reaction of 2-ethynylanthraquinone and a 5’O-DMTr 8-bromo deoxyadenosine derivative (5’-O-dimethoxytrityl-8-bromo-2’-deoxyadenosine
3’-dibenzyl phosphate). The ethylenyl linker was obtained by reduction of an ethynyl linker
with 10% Pd/C under H2. This ethynyl linker was prepared in the same procedure above except
that a different 5’-O protecting group, t-butyldiphenylsilyl group, was used. This was because
that the 4,4’-dimethoxytrityl group was cleaved during reduction of the ethynyl linkers.
Uridine has also been linked to AQ. Saito and co-workers covalently linked AQ to
deoxyuridine via a conventional phosphoramidite procedure (Okamoto et al., 2004; Tanabe et al.,
2006; Yamada et al., 2008). The amine linker in deoxyuridine was prepared by the reaction of
deoxyuridine amide and 2-anthraquinonecarboxylic acid N-hydroxysuccinimide ester. Barton
and co-workers linked AQ to oligonucleotides with an ethynyl linker after DNA synthesis
(Gorodetsky et al., 2007). DNA with 5-ethynyluracil was first synthesized on beads. To the
beads in DMF/TEA (3.5:1.5) in a flask were added 2-iodoanthraquinone, CuI, and Pd(Ph3P)4.
The AQ-linked DNA was then cleaved from the beads.
In the third approach to AQ – DNA electron transfer studies, AQ has been covalently
attached to the sugar of a deoxynucleotide at the 1’, 2’, 3’, or 5’-position (Ono et al., 1993;
Gasper & Schuster, 1997; Whittemore et al., 1999; Connors et al., 2003). AQ was linked to 1’position of the sugar on 2’-deoxyuridine by Matsuda (Ono et al., 1993). A solution of
anthraquinone-2-carboxylic acid and thionyl chloride in DMF/pyridine was added to a solution
of modified deoxyuridine {1’-[[[N-[4-[(9-fluorenylmethoxycarbonyl)amino]-

3
butyl]carbamoyl]oxy]methyl]-3’,5’-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-2’deoxyuridine}. The purified mixture was treated with tetrabutylammonium fluoride to give an
AQ linker at 1’-position. A modified deoxyuridine with an AQ linker at 2’-position has been
synthesized via two methods (Whittemore et al., 1999; Connors et al., 2003). Chambers linked
AQ to 2’-OH via an 8-atom amide linker by stirring a solution of 9,10-anthraquinone-2carboxylic acid 2,3,4,5,6-pentafluorophenyl ester and modified uridine in pyridine/methylene
chloride (Whittemore et al., 1999). Richert linked AQs to the end of oligonucleotides on solid
supports via amide linkers (Connors et al., 2003). A solution of anthraquinone-2-carboxylic acid,
hydroxybenzotriazole monohydrate, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium
hexafluorophosphate, and diisopropylethylamine in DMF was added to prepared
oligonucleotides on beads. The nucleotide products were deprotected by 20% aqueous acetic
acid and finally released from the solid supports. AQ can be connected to 5’-OH of a
deoxynucleotide. Schuster and co-workers coupled an AQ to the 5’-OH terminious of an
oligonucleotide in the final step of DNA synthesis (Gasper & Schuster, 1997).

1.1.2 The study of bases on electron transfer (ET) in DNA molecules.

Upon irradiation DNA molecules can produce base radical cations (Burrows & Muller,
1998; Giese, 2002). If there is G, which has the lowest reduction potential among all four bases
(G•+  A•+  C•+  T•+ at pH = 7) (Steenken & Jovanovic, 1997), a G oxidation product is
observed (Burrows & Muller, 1998; Giese, 2002). This observation is consistent with the idea
that relative ionization potentials of nucleobases determine the oxidation site in DNA.

4
In one study, Giese and co-workers designed a series of DNA duplexes with 4’-acylated
guanosine at one end, different length of (AT)n base pairs in the middle, and triple GGG at the
other end (Giese et al., 2001). 4’-Acylated guanosine was used to generate initial G•+ upon
photolysis. The G•+ irreversibly reacted with H2O and produced cleavage products after
piperidine treatment. Cleavage at GGG sites showed that electrons travelled across consecutive
adenines. More cleavage at GGG sites than at initial G sites was consistent with the hypothesis
that the ET rate was faster than the reaction rate between G•+ and H2O. The cleavage product
ratio PGGG/PG decreased by a factor of 8 for addition of one AT base pair in (AT)n (1  n  3); the
ratio PGGG/PG in the range of 4.5 – 2.0 decreased slightly with the addition of AT base pairs in
(AT)n (4  n  16). This observation indicated that the average ET rate constant between two G
sites was highly distance dependent in short strands (1  n  3) and weakly distance dependent
while 4  n  16.
Joy et al. designed four DNA duplexes with an AQ group covalently linked to the
phosphate at the 5’-end of one strand and a 32P label at the 5’-end of the complementary strand
(Joy et al., 2006; Ghosh et al., 2008). Two of the duplexes will be discussed below, one with
only AT base pairs in the middle (DNA-1), and the other one with the same AT base pairs and a
GG step in the middle (DNA-2). Both DNA samples were irradiated, oxidized by Na2IrCl6,
treated with piperidine, and analyzed with the Maxam-Gilbert sequencing method. A control
experiment without irradiation showed no cleaved DNA fragments on the sequencing gel. This
observation showed that irradiation was essential for generating AQ radical anions. A control
experiment with irradiation but no piperidine treatment showed very faint cleavage bands.
Complete treatment of DNA-1 gave cleavage at both T and A sites, consistent with the
hypothesis that the ET rate was faster than the reaction rate between base radical cations and
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piperidine. More cleavage bands at T sites were observed than at A sites. This observation was
inconsistent with the fact that the reduction potential of A•+ is lower than that of T•+, and
suggested that the relative reactivity of base radical cations determined the oxidation product of
DNA. Complete treatment of DNA-2 showed predominant cleavage at GG sites and much less
cleavage at other sites. This observation was consistent with G•+ having the lowest reduction
potential of the four bases.
Barton and co-workers created a DNA duplex with a covalently attached rhodium
complex at the 5’-end adenine of one strand and a cyclopropyladenine (CPA) at the far end of an
A-tract in the complementary strand (Augustyn et al., 2007). The rhodium complex is a strong
oxidant which can oxidize covalently linked A upon photoirradiation. The propyl ring of
cyclopropyladenine radical cation (CPA•+) can easily be opened, and the ring opened form can
then react with H2O or O2. The observation of ring opened products upon photolysis indicated
that electrons transferred across A-tracts. In a second experiment, a series of DNA duplexes
were created with the CPA at serial positions along the A-tracts. After 30 s of photolysis, the
yield of ring opened products was 62 – 78% for all of the duplexes. This was consistent with
that the electron transfer rate being faster than the cyclopropane ring opening rate.
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Published work – Synthesis, electrochemistry and hydrolysis of anthraquinone
derivatives
Yu Cao, Daniel J. Rabinowitz, Dabney W. Dixon,* and Thomas L. Netzel
Department of Chemistry, Georgia State University, Atlanta, Georgia, USA 30302-4098

Abstract.
Anthraquinone (AQ) derivatives, including members of the anthraquinone imide (AQI) family,
have been synthesized to afford good candidates for electron transfer studies in DNA. Electron
withdrawing groups on the anthraquinone ring give a less negative reduction potential, as desired.
As expected, the AQI derivatives have less negative reduction potentials than AQ derivatives.
The AQI ring system has a half-life for hydrolysis of about 75 min in a 7:3 solution of 0.005 M
of K2CO3 in methanol and acetonitrile.

Keywords.
electron transfer, anthraquinone bisamide, anthraquinone imide, hydrolysis, DNA

Introduction.
The role of adenine (A) in DNA electron transfer has been the focus of a number of recent
studies (Hussein et al., 2006; Giese et al., 2001; Joy et al., 2006; Ghosh et al., 2008; Augustyn et
al., 2007; Genereux et al., 2008; Lewis et al., 2006; Lewis et al., 2008; Adhikary et al., 2008;
Kawai et al., 2008). Although adenine has the second lowest reduction potential among all four
bases (Steenken & Jovanovic, 1997), recent work has shown that in duplex DNA containing only
adenine and thymine (T), T oxidation products predominate (Joy et al., 2006; Ghosh et al., 2008).
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This is presumably due to the high reactivity of the thymine radical cation (Joy et al., 2006;
Ghosh et al., 2008). Netzel and co-workers (Hussein et al., 2006; Abou-Elkhair & Netzel, 2005a)
as well as Tierney and Grinstaff (Tierney & Grinstaff, 2000) have created derivatives in which
the adenine is covalently attached to an anthraquinone (AQ). Further studies would be aided by
systems with a higher driving force for electron transfer. The driving force can be increased by
adding electron withdrawing groups or extending the conjugation of the AQ ring system. The
anthraquinone imide (AQI) is of interest in this regard (Todd et al., 2005; Shamsipur et al., 2007;
Qiao et al., 2008; Breslin et al., 1997a). The reduction of AQI (Todd et al., 2005) is about 120
mV less negative (and hence more favorable to formation of the radical anion) than that of AQ
(Shamsipur et al., 2007) (E11/2 values in MeCN).
The goal of this study was to synthesize AQ derivatives with electron withdrawing groups
and measure the electrochemical properties of these compounds. A variety of strategies to attach
these molecules to adenine could be envisioned; the propargyl AQI 5c was designed so that
palladium coupling chemistry could be used to attach this molecule to a bromoadenine derivative.
Because the long term goal of this work is to incorporate these derivatives into DNA, and this
incorporation commonly uses basic conditions for cleavage from the solid supports (Venkatesan
et al., 2003), we also studied the base-catalyzed hydrolysis of the AQI.

Results and Discussion.
The AQ derivatives were synthesized as shown in Scheme 1.1. The AQ bisamide was
prepared from dimethyl anthraquinone-2,3-dicarboxylate, while the AQI was made from either
dimethyl anthraquinone-2,3-dicarboxylate or anthraquinonedicarboxylic acid anhydride. The
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AQ bisamide preparation requires milder conditions (lower temperature and shorter reaction time)
than does AQI synthesis.
Redox potentials for the AQ derivatives are shown in Table 1.1. Addition of two amide
groups raises the first reduction potential by ≈ 170 mV, while the addition of two ester groups
has a larger effect, raising the reduction potential by ≈ 255 mV with respect to AQ itself. The
AQI derivatives have even less negative reduction potentials, ≈ 365 mV less negative than AQ
itself. Thus, AQI derivatives have the higher driving force for electron transfer by at least 100
mV.
Covalent attachment of these derivatives to DNA would necessitate a base deprotection
step. The anthraquinone ring itself is stable to base deprotection conditions. To see if the AQI
ring would also be stable, we monitored the UV-visible spectrum of AQI 5b under basic
conditions. In 3:7 MeCN and 60 mM pH = 8.0 aqueous sodium tetraborate solution, the
absorbance of a sample of 5b increased at 208 nm and decreased at 230 nm with an isosbestic
point at 219 nm (Figure 1.1). The half-life of the hydrolysis was approximately 45 min. Base
deprotection in DNA synthesis can be effected with 0.05 M K2CO3 in MeOH (Venkatesan et al.,
2003). These conditions gave rapid hydrolysis of the AQI system. Even with a 10-fold lower
concentration of K2CO3, the half-life for hydrolysis was approximately 75 min (3:7 MeCN and
0.005 M K2CO3 in MeOH, data not shown). The AQI ring may therefore be most useful when
covalently attached to a peptide nucleic acid (PNA) (Armitage et al., 1997), as this does not
require the base hydrolysis step. In contrast, the AQ derivatives bearing electron withdrawing
groups, with minor alterations in the side chains depending on the desired DNA base attachment
point, are promising candidates for incorporation into DNA.
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Experimental.
Materials and General Methods.
Chemicals were purchased from Alfa-Aesar, TCI America, and Aldrich. Thin layer
chromatography (TLC) was run using 2.5 - 10.0% MeOH in CH2Cl2 as the eluent on Silica Gel
60 F254 Precoated Plates from EMD Chemicals Inc. Flash column chromatography was carried
out on Sorbent Technologies silica gel (standard grade, 60 Å porosity, 230 - 400 mesh) that was
packed in glass columns and pressurized with boil-off nitrogen. NMR spectra were recorded on
a Brucker Avance 400 using either CDCl3 or DMSO-d6 as solvents. Mass spectra (MS) were
recorded in either positive or negative ion modes on a Waters Micromass Q-TOFTM with 5 ppm
accuracy. High-resolution (HR) MS were obtained with electrospray ionization (ESI). UVvisible absorbance spectra were recorded on a UV-2501PC spectrometer (Shimadzu). Melting
points were recorded via a microscope (Cambridge QUANTIMET 900) and a hot-stage (Mettler
FP800); melting points are corrected.

Electrochemistry.
Two one-electron reduction potentials of anthraquinone derivatives were measured in
anhydrous acetonitrile with 0.10 M tetrabutylammonium hexafluorophosphate (TBAH) as the
supporting electrolyte. The cyclic voltammograms were obtained using a CHI Instruments
electrochemical workstation with a PC for data acquisition. The measurements were taken using
a three-electrode system: platinum working and auxiliary electrodes and a 0.01 M Ag/Ag+ in 0.1
M TBAH CH3CN reference electrode. The scan rate was set to 100 mV/s. The measurements
are reported in SCE. The reduction potential data of AQ itself are similar to those in acetonitrile
with 0.1 M TBAP (Shamsipur et al., 2007). AQI derivative 5a did not give clean reduction
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potential data, in line with previous studies on the phthalimide system (Leedy & Muck, 1971;
Orzeszko et al., 1998).

Dimethyl anthraquinone-2,3-dicarboxylate (2) (Tarnchompoo et al., 1987; Mehta et al., 1994).
Anthraquinone-2,3-dicarboxylic acid 1 (Lohier et al., 2006) (3.23 g, 12.3 mmol) was
esterified in refluxing anhydrous methanol (MeOH, 133 mL, 36.9 mol) containing 98% H2SO4
(3.2 mL) for 1 d to afford 2 (3.15 g, 89%). The 1H NMR spectra matched that in the literature
(Mehta et al., 1994).

N,N'-Dipropyl-anthraquinone-2,3-dicarboxamide (4a).
Compound 2 (27 mg, 0.083 mmol) was dissolved in 0.5 mL THF. n-Propylamine (1.5
mL, 18 mmol) was added and the resulting solution was stirred at rt for 19 h. The solvent was
removed under vacuum; the residue was purified via a silica gel chromatography eluted with
MeOH/CH2Cl2 (0:100-2:98) to afford 4a (31 mg, 98%) as a yellow solid: 1H NMR (400 MHz,
DMSO-d6)  8.64 (t, J = 5.6 Hz, 2H, NH), 8.26-8.23 (m, 2H, Ar), 8.17 (s, 2H, Ar), 8.00-7.96 (m,
2H, Ar), 3.22-3.18 (m, 4H, NHCH2), 1.59-1.50 (m, 4H, CH2CH3), 0.94 (t, J = 7.6 Hz, 6H, CH3);
C NMR (100 MHz, DMSO-d6)  182.2, 167.0, 142.1, 135.3, 133.5, 127.4, 126.3, 41.4, 22.7,
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11.9; HRMS (ESI) calcd for C22H21N2O4 (M – H+) 377.1501, found 377.1500. Mp 214 - 217 oC.

N,N'-Bis(3-methoxypropyl)-anthraquinone-2,3-dicarboxamide (4b) was prepared as
described above for 4a as a pale yellow solid (79%). 1H NMR (400 MHz, DMSO-d6)  8.65 (t, J
= 5.6 Hz, 2H, NH), 8.28-8.26 (m, 2H, Ar), 8.19 (s, 2H, Ar), 8.00-7.98 (m, 2H, Ar), 3.43 (t, J =
6.4 Hz, 4H, CH2O), 3.30-3.27 (br, 10H, CH3, NHCH2), 1.78-1.75 (m, 4H, NHCH2CH2); 13C
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NMR (100 MHz, DMSO-d6)  182.2, 167.0, 142.0, 135.3, 133.6, 127.4, 126.3, 70.1, 58.4, 37.0,
29.5; HRMS (ESI) calcd for C24H27N2O6 (M + H+) 439.1869, found 439.1886. Mp 189 - 192 oC.

Anthraquinone-2,3-dicarboximide (5a) (Willgerodt & Maffezzoli, 1911).
Ammonium hydroxide solution (28%, 5 mL) was added to the solution of 2 (30 mg) in
MeOH/THF (1:1, 4 ml) at 59 oC. The mixture was stirred at rt for 4 h, purified via a silica gel
chromatography eluted with MeOH/CH2Cl2 (0:100-10:98) to afford 5a (4 mg, 16%) as a yellow
solid: 1H NMR (400 MHz, DMSO-d6) 11.92 (s, 1H, NH), 8.45 (s, 2H, Ar), 8.29-8.27 (m, 2H,
Ar), 8.02-7.99 (m, 2H, Ar); 13C NMR (100 MHz, DMSO-d6)  181.5, 167.9, 137.7, 136.6, 135.1,
132.9, 127.1, 120.8.

n-Propargyl-anthraquinone-2,3-dicarboximide (5c).
Anthraquinonedicarboxylic acid anhydride (3) (Fairbourne, 1921) (30 mg, 0.11 mmol),
anhydrous DMF (3.0 ml), and propargylamine (7.3 L, 0.11 mmol) were sequentially added to a
flask under nitrogen. The resulting mixture was stirred at 80 oC under nitrogen for 3.5 d, dried
under vacuum, and separated by a silica gel chromatography eluted with MeOH/CH2Cl2 (0:1002:98) to afford 5c (16 mg, 47%) as a yellow solid: 1H NMR (400 MHz, CDCl3)  8.82 (s, 2H,
Ar), 8.38-8.34 (m, 2H, Ar), 7.90-7.85 (m, 2H, Ar), 4.52 (d, J = 2.4 Hz, 2H, CH2), 2.25 (t, J = 2.4
Hz, 1H, CCH); 13C NMR (100 MHz, CDCl3)  181.4, 165.2, 138.2, 135.7, 135.0, 133.1, 127.8,
123.0, 72.1, 27.1; HRMS (ESI) calcd for C19H9NO4 (M•-) 315.0532, found 315.0540. Mp 271 274 oC.
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N-(3-methoxypropyl)-anthraquinone-2,3-dicarboximide (5b) was prepared as described
above for 5c as a yellow solid (21%). 1H NMR (400 MHz, CDCl3)  8.77 (s, 2H, Ar), 8.38-8.33
(m, 2H, Ar), 7.89-7.84 (m, 2H, Ar), 3.86 (t, J = 6.8 Hz, 2H, CH2O), 3.44 (t, J = 6.0, 2H, NCH2),
3.26 (s, 3H, CH3), 2.00-1.94 (m, 2H, NHCH2CH2); 13C NMR (100 MHz, CDCl3)  181.6, 166.6,
138.0, 136.0, 134.9, 133.1, 127.7, 122.5, 70.2, 58.7, 36.4, 28.4; HRMS (ESI) calcd for
C20H15NO5 (M•-) 349.0950, found 349.0951. Mp 236 - 239 oC. AQI derivative 5b appeared to
give a new species on repeated cycles of reduction and oxidation.
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Figure 1.1 UV-visible absorbance spectra of AQI 5b as a function of time at room temperature
(3:7 MeCN and 60 mM pH = 8.0 borate buffer). Scans were taken every 15 min for the first 2 h
and every 1 h for the last 3 h. The absorbance increased at 208 nm and 285 nm, and decreased at
230 nm.
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Table 1.1 Reduction potentials of AQ derivatives in acetonitrile (vs. SCE, 1 mM AQ with 0.1 M
TBAH).
Compound

E1½

E2½

AQ

-0.939

-1.649

2

-0.683

-1.278

4a

-0.772

-1.393

4b

-0.762

-1.362

5b

-0.591

-1.098

5c

-0.556

-1.102
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2.1

Synthesis of tetraarylporphyrin with an intramolecular sulfone bridge.

Introduction.

2.1.1 Synthesis of tetraphenylporphyrins (TPP) with internal cyclic ketones, enamines,
and thioketones.

Cycloketo-tetraphenylporphyrins (Figure 2.1) can be synthesized via TPP (Figure 2.2)
intramolecular condensations. One method is to introduce the cycloketone bridge starting from a

-formyl substituents. Tasker and co-workers found in 1980 that the monocycloketone in a sixmembered ring was generated from demetalation of -formyl-meso-tetraphenylporphyrin copper
complexes in trifluoroacetic acid (TFA) at 60 oC ( 0.1%) (Henrick et al., 1980). Ten years later,
Callot et al. increased the yield to approximately 40% by using 6% TFA in CH2Cl2 at 20 oC
(Callot et al., 1990). Carboxylic acid groups at ortho-positions of phenyl rings can also serve as
the carbonyl moiety. Richeter et al. synthesized a six-membered cycloketone with a single-atom
bridge [TPP(3,5-tBu)CcH2, Figure 2.1, 87%] by reacting oxalyl chloride and SnCl4 with mesotris(3,5-di-tert-butylphenyl)-mono-ortho-carboxylphenylporphyrin (Richeter et al., 2002). Röder
and co-workers synthesized a seven-membered cycloketone with a two carbon bridge (CH2CO)
[TPP(3,5-tBu)C2CH2, Figure 2.1] by using the same catalysts and copper (II) complexes of
meso-tris(3,5-di-tert-butylphenyl)-monophenylporphyrin containing an ortho-acetic acid on the
phenyl ring (Jasinski et al., 2007).
The six-membered cyclic enaminoporphyrin (TPPNcNi, Figure 2.1) was prepared via
cyclization of a -nitroporphyrin and a meso-aryl group (Richeter et al., 2004). The nitroporphyrin (2-nitro-meso-tetraarylporphyrin) was synthesized via reaction of nickel TPP and
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LiNO3 in CHCl3/AcOH/Ac2O (90 – 95%); TPPNcNi was synthesized via reaction of 2-nitromeso-tetraarylporphyrin and triethyl phosphite (70 – 75%).
The six-membered cyclothioketone TPP [TPP(3,5-tBu)CCS/NH2Ni, Figure 2.1] was
prepared by the conversion of a carbonyl group in the corresponding TPP cycloketone into a
thiocarbonyl group in 97% yield using Lawesson’s reagent [2,4-bis-(4-methoxyphenyl)-1,3dithia-2,4-diphosphetane-2,4-disulfide] (Richeter et al., 2004).

2.1.2 Absorbance spectra of porphyrins with internal cycloketones, cycloenamines, and
cyclothioketones.

Conjugation extension via the cyclic ring results in a bathochromic shift of the Soret band
in the UV-visible spectrum (Table 2.1 and Table 2.2). The observed shift is a very strong
function of the structure of the molecule. For non-metallated TPP derivatives, addition of one
cycloketone induced a 47 nm red shift (CH2Cl2) (Table 2.1) (Callot et al., 1990; Richeter et al.,
2002; Hogan et al., 2006; Chan et al., 2008). For nickel TPP compounds, addition of one
cycloketone induced about a 50 nm red shift (in CH2Cl2) (Callot et al., 1990; Siri & Smith, 2003);
addition of one cycloenamine induced a 14 nm red shift compared to NiTPP itself (CH2Cl2)
(Table 2.2) (Richeter et al., 2002; Siri & Smith, 2003). These data suggest that in the same
solvent, internal cycloketones result in a larger red shift compared to internal cycloenamines.
Further extension of the conjugation in TPP shows an even greater red shift of the Soret
band. For example, a second six-membered cycloketone in TPP(3,5-tBu)H2 or TPP(3,5-tBu)Ni
has a 2 – 76 nm red shift, depending on the structural isomer, compared to the corresponding
monocycloketone (Richeter et al., 2003). As examples, the dicycloketone TPP compound
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[TPP(3,5-tBu)Cc2H2, IV, Figure 2.3] has a 2 nm red shift whereas TPP(3,5-tBu)Cc2H2, II,
(Figure 2.3) has a 76 nm red shift.
Addition of a methylene group adjacent to the cyclic ketone reduces the red shift. Thus,
the seven-membered internal cyclic ketone with a CH2CO bridge [TPP(3,5-tBu)C2CH2] has a
22.3 nm red shift (vs. TPPH2) compared to the corresponding structure without the methylene
group [TPP(3,5-tBu)CcH2] which has a 46.8 nm red shift (all data in DMF) (Barber et al., 1992;
Jasinski et al., 2007).

2.1.3 Sulfonated porphyrins in phenyl rings and β-pyrrole positions.
2.1.3.1 Ribó group’s work on sulfonation of 5,15-bis(phenyl)porphyrin.
García-Ortega and Ribótreated 5,15-bis(phenyl) porphyrin (DPP) with fuming
H2SO4/MeOH (9:1) at rt for 20 min; a mixture of tri- and tetra-sulfonated products (ratio of 2.5:1)
were produced (García-Ortega & Ribó, 2000). These two purified products had Soret bands at
407 and 414 nm, respectively, in MeOH. Treatment of DPP in concentrated H2SO4 for different
times at different temperatures resulted in more complicated product mixtures of mono-, di-, and
tri-sulfonated porphyrins with sulfonation at both the para-phenyl and -pyrrole positions. The
amounts of various products were a function of the percentage of SO3 in H2SO4, the reaction
time, and the temperature; it was suggested that desired products could be maximized by
adjusting the reaction conditions. Different red shift data for the sulfonated DPP were observed
for sulfonation at different positions. Approximate red shifts of the Soret in MeOH were 6 nm
for a bridge sulfonic acid, 4 – 5 nm for a -pyrrole sulfonic acid, and  1 nm for a para-phenyl
sulfonic acid.
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2.1.3.2 Mansuy group’s work on β-pyrrole sulfonation of TPP.
Mansuy and co-workers prepared tetraphenylporphyrins with four sulfonic acids at the βpyrrole positions [meso-tetrakis(2,3,5,6-tetrafluorophenyl)tetrasulphonatoporphyrin (TPPF4S4)
and meso-tetrakis(pentafluorophenyl)tetrasulphonatoporphyrin (TPPF5S4)] by sulfonation of
TPPF4 and TPPF5, respectively, with fuming H2SO4 at  100 oC for 10 h (Artaud et al., 1991;
Artaud et al., 1993). They performed 1H NMR on the TPPF5S4 product and identified it to be a
mixture of isomers via four pyrrolic proton singlets in the spectrum (Artaud et al., 1993). There
are four isomers each for TPPF4S4 and TPPF5S4 (Figure 2.4). The pyrrole protons are expected
to show as eight singlets in 1H NMR spectra, one singlet for Figure 2.4a, four singlets for b, two
singlets for c, and two singlets for d which due to the symmetry in each structure. In each
isomer, the singlets should appear with the same area. The Soret absorbance of TPPF4S4 is red
shifted by approximately 13 nm compared to porphyrins with no sulfonic acids in the β-pyrrole
positions (e.g., TPPS4) (Artaud et al., 1991; Aggarwal & Borissevitch, 2006). The red shift of 3
– 5 nm for each -pyrrole sulfonic acid on TPP is consistent with Ribó’s observations that
approximate red shift of 4 – 5 nm was for a -pyrrole sulfonic acid on sulfonated DPP.

2.1.4 TPP with multi-sulfonate groups ( 4) on the phenyl rings.

Tetraphenylporphyrins can be sulfonated to give major products as a tetrasulfonated or
octasulfonated species, depending on the structure of the starting materials and the conditions of
the reaction (Zipplies et al., 1986; Hoffmann et al., 1990; Song et al., 1998). Bruice and coworkers allowed zinc(II)-meso-tetrakis(2,6-dimethylphenyl)porphyrin to react with concentrated
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H2SO4 at 100 oC for 4 h and obtained a tetrasulfonated product (yield > 40%) (Zipplies et al.,
1986). Meunier and co-workers synthesized an octasulfonated species at by allowing mesotetramesityl-β-octabromoporphyrins to react with fuming H2SO4 at 120 oC for 4 – 5 h; both
meta-phenyl positions on each ring were sulfonated in an overall yield  70% (Hoffmann et al.,
1990). They also prepared meso-tetrakis(3,5-disulfonatomesityl)porphyrin (yield  70%) by
reacting meso-tetramesitylporphyrin with fuming H2SO4 at 80 oC for 40 min (Song et al., 1998).
None of the experiments with tetramesitylporphyrin gave sulfonation at the pyrrole positions, in
contrast to sulfonation of TPP itself. The electron donating methyl substituents on the pyrrole
ring appear to control the position of sulfonation. Each sulfonic acid on a phenyl ring in
TMPS8H2 (Figure 2.1) results in approximately 1 nm red shift of the Soret absorbance compared
to TPPS4 (data in aqueous solution, Table 2.3) (Aggarwal & Borissevitch, 2006; Hoffmann et al.,
1990). This data is consistent with that of the Ribógroup (García-Ortega & Ribó, 2000)
showing that sulfonation of the phenyl positions has only a small effect on the Soret absorbance.
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Published work – Synthesis and characterization of a water-soluble porphyrin with a
cyclic sulfone
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Abstract.
Water-soluble sulfonated tetraarylporphyrins are studied in a wide variety of contexts
including as analytical reagents and as possible agents in cancer photodynamic therapy as well as
in antiviral and antidiabetic applications. Herein, we report the first synthesis of a
pentasulfonated porphyrin bearing an internal cyclic sulfone ring. Treatment of 5,10,15,20tetrakis(4-sulfonatophenyl)porphyrin (TPPS4) with fuming H2SO4 gave a structure consistent
with initial sulfonation followed by dehydration to give a sulfone bridge between an orthoposition of one of the phenyl groups and a β-pyrrole position on the porphine ring (TPPS4Sc).
The structure was established by electrospray mass spectrometry and 1H NMR. The Soret UVvisible absorption is red shifted by about 32 nm compared to that of TPPS4.
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Sulfonated tetraphenylporphyrins [e.g., 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrin,
TPPS4] are increasingly used in a variety of contexts. A wide variety of derivatives are now
known, with the large majority having one sulfonic acid per phenyl ring (Hambright, 2000).
Sulfonated porphyrins have been shown to inhibit the human immunodeficiency virus (Dixon et
al., 1990; Vzorov et al., 2002; Dixon et al., 2005; Vzorov et al., 2007; Song et al., 1997; Dairou
et al., 2004; Vargas et al., 2008). Porphyrins with more than four sulfonic acids have been
shown to be active, specifically the octasulfonated mesityl porphyrin (Song et al., 1997) and
mixtures of sulfonated naphthylporphyrins in which many of the components have more than
four sulfonic acids per porphyrin (Dixon et al., 2005). We wished to develop approaches to
additional sulfonated tetraphenylporphyins. Herein we report that reaction of TPPS4 with
fuming sulfuric acid gives the first member of a new class of porphyrins in which a sulfone
group serves as a bridge between a phenyl ring and a β-pyrrole position.

TPPS4 is commonly made from meso-tetraphenylporphyrin (TPP) and concentrated
H2SO4 (Hambright, 2000). In our hands, treatment of TPPS4 with this reagent under dark for 14
d at rt did not result in any further sulfonation of the porphyrin. However, treatment with fuming
H2SO4 for 2 h at rt (Scheme 2.1), followed by removal of water and dissolution of the residue in
methanol gave a mixture with substantial absorbance at about 440 nm. High performance liquid
chromatography (HPLC) of the mixture visualized at 410 nm showed that it was predominantly
the starting material TPPS4 (eluting at 14.0 min) with no other peak > 5% of this peak (Figure
2.5). However, when the chromatogram was visualized at 450 nm, a strong new peak eluting at
13.2 min was observed. Under these chromatographic conditions, tri(4-sulfonatophenyl)monophenyl-porphyrin [TPPS3] elutes at 20.5 min (Figure 2.6). Thus, the new compound was
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likely to have a net charge of -4 under the chromatographic conditions. When the reaction time
was lengthened to 6 h, the peak at 13.2 min decreased in intensity and a second new peak
appeared at 12.4 min when the chromatogram was visualized at 450 nm. When the reaction time
was lengthened to 24 h, many small components absorbing at 450 nm were seen. To isolate the
first-formed of the new products, the fuming H2SO4 treatment was stopped after 2 h to simplify
the reaction mixture components. The product eluting at 13.2 min (TPPS4Sc) was isolated. The
reaction mixture was purified via HPLC on an analytical C-18 column (ZORBAX Eclipse XDBC18, 4.6 × 150 mm) with an elution of 5% MeOH in NH4OAc buffer (20 mM, pH = 7.7)
gradient to 60% MeOH over 15 min at 1.000 ml/min to give TPPS4Sc: 1H NMR (500 MHz,
DMSO-d6) 9.80 (d, 1H, cyclized phenyl proton beside the sulfone group), 8.99-8.56 (7H,
pyrrole), 8.27-8.05 (m, 14H, phenyl). HRMS (ESI) calcd for C44H27N4O14S5 (M - H+)
995.0127, found 995.0117.

TPPS4Sc has a Soret band at 444 nm and weak Q bands at 554, 602, and 693 nm (Figure
2.7). The bands are red shifted compared to TPPS4. In particular, the Soret band of TPPS4Sc is
red shifted by about 32 nm. Red shifts of the Soret band are commonly due to protonation of the
inner nitrogens [which have a pKa of about 5.0 (Hambright, 2000)]. However, this long
wavelength Soret band was also observed under basic conditions. The red shift of about 32 nm
in aqueous solution is too large to be ascribed to sulfonation at the β-pyrrole position; sulfonation
at this position results in a bathochromic shift of 3 – 5 nm per sulfonic acid (Artaud et al., 1993;
García-Ortega & Ribó, 2000). Another possibility is that the conjugation of the ring has been
extended. The most likely structure is one in which initial sulfonation is followed by loss of
water to give an intramolecular sulfone (Hajipour et al., 2005; Alizadeh et al., 2007). This
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sulfone is expected to have a UV-visible absorbance at longer wavelength as has been observed
in the studies of the monocycloketo-porphyrins. The addition of a cyclic keto bridge results in a
37 nm red shift compared to TPP itself (data in CH2Cl2) (Hogan et al., 2006; Richeter et al.,
2002). The Soret of a cyclic enamine nickel porphyrin is red shifted by 14 nm compared to the
parent NiTPP (data in CH2Cl2) (Siri & Smith, 2003; Richeter et al., 2004).

The high resolution mass spectrum of TPPS4Sc gave a molecular formula of
C44H27N4O14S5, consistent with a structure in which SO2 had been added to the molecule. The
negative-ion mode electrospray mass spectrum [(-)ESI-MS] indicated that the parent compound
(M, 996) lost one (M – H+, 995), two [(M – 2H+)/2, 497] and three [(M – 3H+)/3, 331] protons to
give net charges of -1, -2 and -3, respectively (Figure 2.9). The MS/MS spectrum showed a clear
pattern of fragmentation (Figure 2.10). The parent ion (M – H+, 995) lost SO2 (64) to give peaks
at 931 and 867, assigned as M – SO2 – H+ and M – 2SO2 – H+. Loss of SO2 has been observed
previously for sulfonated tetrapyrroles (Dixon et al., 2004). The 1H NMR showed complicated
sets of peaks for the pyrrole and phenyl protons because of the sulfone-induced asymmetry
(Figure 2.11). Integration indicated that one of the phenyl photons shifted downfield by 0.3 – 0.9
ppm to the pyrrole proton region; this is presumably the proton between the sulfonic acid and the
sulfone group. Similar large downfield chemical shifts have been observed for benzene
hydrogens between two sulfonic acids (Cerfontain et al., 1994).

As outlined above, sulfonation for longer times gave additional species. The component
eluting at 12.4 min had a Soret maximum of 452 nm (diode array HPLC). This red shift indicates
an additional extension of the conjugation. This species is therefore likely to have a second
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sulfone bridge (six isomers possible). In the nickel cyclic ketoporphyrin series, a second ketone
bridge results in an additional 7 – 75 nm red shift depending on the isomer formed (Richeter et
al., 2003).

The cyclic sulfone structure also explains the spectra of sulfonated difluoroTPP
derivatives studied as anti-HIV therapeutic agents (Vzorov et al., 2002). The spectral
characteristics of the Cu chelates of sulfonated difluoroTPP derivatives (Scheme 2.1) were
strongly dependent on the positions of the fluorine substituents (Figure 2.8). TPP with fluorines
at the 2- and 4-positions gave a product mixture with a max at 412 nm, indicating no formation
of the cyclic sulfone. This is in line with expected sulfonation patterns; fluoro groups are
predominantly para (99.1%) and ortho (0.9%) directing for sulfonation (March, 1992). Sulfonic
acids at the 3- and 5-positions would not be close enough to the pyrrole rings to form an
intramolecular sulfone. In contrast, TPP with fluorines at the 3- and 5-positions gave a product
mixture with a broad, short band at 448 nm with a slight shoulder at about 490 nm. The 3,5difluoro substituent pattern would result in sulfonation at the 2-, 4-, and 6-positions; the 2- and 6sulfonic acids would be able to form cyclic sulfones, thus resulting in a significant red shift of
the Soret of the product mixture. The 2,3-difluoro- and 2,5-difluorotetraphenylporphyrins had
445 - 450 nm spectral bands in addition to the Soret at 415 - 420 nm. These spectra were
consistent with mixtures of products, with only some components able to cyclize to the sulfone,
as expected from the ortho, para directing nature of the fluorine substituents. The initial position
of sulfonation could be either on the phenyl ring or on the porphine ring; sulfonation can occur at
the -pyrrole positions for selected structures (Artaud et al., 1993; García-Ortega & Ribó, 2000).
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In conclusion, sulfonation of TPPS4 with fuming H2SO4 adds one or more additional
sulfonic acids to the molecule. The cyclic sulfone form of tetraphenylporphyrin (TPPS4Sc) has
been reported for the first time. This cyclic sulfone structure explains previous observations on
spectra of difluorotetraphenylporphyrin derivatives and gives a direct synthesis of sulfonated
porphyrins with red-shifted spectra, which may be useful in a variety of studies.
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Figure 2.5 HPLC/UV-visible chromatograph of the TPPS4 sulfonation product visualized at 410
nm (blue) and 450 nm (red) from the HPLC separation on a ZORBAX Eclipse XDB-C18 (4.6 ×
150 mm) column with an elution gradient of 5% MeOH in NH4OAc buffer (20 mM, pH = 7.7) to
60% MeOH over 15 min. TPPS4 elutes at 14.0 min.
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Figure 2.6 HPLC/UV-visible chromatograph of the mixture of TPPS4 and TPPS3 visualized at
410 nm (blue) and 450 nm (red) from the HPLC separation on a ZORBAX Eclipse XDB-C18
(4.6 ×150 mm) column with an elution gradient of 5% MeOH in NH4OAc buffer (20 mM, pH =
7.7) to 60% MeOH over 15 min. TPPS3 elutes at 20.5 min. TPPS4 elutes at 14.0 min.
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Figure 2.7 Normalized absorption spectra of TPPS4 [blue] in NH4OAc aqueous buffer (20 mM,
pH = 7.7) and TPPS4Sc [red] from the HPLC separation on a ZORBAX Eclipse XDB-C18 (4.6
× 50 mm) column with an elution gradient of 5% MeOH in NH4OAc buffer (20 mM, pH = 7.7)
to 38% MeOH over 15 min.
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Figure 2.8 Normalized absorption spectra of the Cu chelates of difluoro derivatives of TPPS4 in
NH4OAc aqueous buffer (20 mM, pH = 7.7).
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Figure 2.9 The negative-ion mode electrospray mass spectrum [(-)ESI-MS] of TPPS4Sc. The
sample in 50% MeOH with 0.5% NH3 was recorded in a negative ion mode on a Waters
Micromass Q-TOFTM instrument.

42

Figure 2.10 The MS/MS spectrum of TPPS4Sc. The sample in 50% MeOH with 0.5% NH3 was
recorded in a negative ion mode on a Waters Micromass Q-TOFTM instrument.
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Figure 2.11 1H NMR of TPPS4Sc in DMSO-d6.
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Table 2.1 The Soret absorbance of TPP with internal cyclic rings in the free base form.
Compound
TPPH2
TPPH2
TPPCcH2
TPP(3,5-tBu)H2
TPP(3,5-tBu)CcH2
TPP(3,5-tBu)CcH2
TPP(3,5-tBu)CC/NH2H2

Soret band (nm)
419
417.2
466
419
466
464.0
456

Solvent
CH2Cl2
DMF
CH2Cl2
CH2Cl2
CH2Cl2
DMF
CH2Cl2

Reference
(Hogan et al., 2006)
(Barber et al., 1992)
(Callot et al., 1990)
(Chan et al., 2008)
(Richeter et al., 2002)
(Jasinski et al., 2007)
(Richeter et al., 2002)

TPP(3,5-tBu)Cc2H2, II

542

CH2Cl2

(Richeter et al., 2003)

TPP(3,5-tBu)Cc2H2, IV
TPP(3,5-tBu)C2CH2

468
439.5

CH2Cl2
DMF

(Richeter et al., 2003)
(Jasinski et al., 2007)

45

Table 2.2 The Soret absorbance of TPP with internal cyclic rings with Ni in the center.
Compound
TPPNi
TPPCcNi
TPPNcNi
TPP(3,5-tBu)Ni
TPP(3,5-tBu)CcNi
TPP(3,5-tBu)CC/NH2Ni
TPP(3,5-tBu)CCS/NH2Ni

Soret band (nm)
412
462
426
414
465
462
496

Solvent
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2

Reference
(Siri & Smith, 2003)
(Callot et al., 1990)
(Richeter et al., 2004)
(Callot et al., 1990)
(Richeter et al., 2002)
(Richeter et al., 2002)
(Richeter et al., 2004)

TPP(3,5-tBu)Cc2Ni, I

516

CH2Cl2

(Richeter et al., 2003)

TPP(3,5-tBu)Cc2Ni, II
TPP(3,5-tBu)Cc2Ni, III
TPP(3,5-tBu)Cc2Ni, IV
TPP(3,5-tBu)Cc2Ni, V
TPP(3,5-tBu)Cc2Ni, VI

540
490
472
524
482

CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2

(Richeter et al., 2003)
(Richeter et al., 2003)
(Richeter et al., 2003)
(Richeter et al., 2003)
(Richeter et al., 2003)
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Table 2.3 The Soret absorbance of sulfonated TPP in the free base form.
Compound
TPPF4S4
TPPF5
TPPF5S4

Soret band (nm)
426
410
428

Solvent
H2O
N/A
H2O

TPPS4

413

H2O (pH = 7)

TPP(2,6-Me)S4
TMPS8H2

413
418

H2O
H2O

Reference
(Artaud et al., 1991)
(Artaud et al., 1993)
(Artaud et al., 1993)
(Aggarwal & Borissevitch,
2006)
(Zipplies et al., 1986)
(Hoffmann et al., 1990)
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3.1

Affinity labeling of heme proteins

Introduction.
The number of known heme enzymes is growing exceedingly rapidly (Tsiftsoglou et al.,

2006; Monzani et al., 2008; Donohue et al., 2009; Tong & Guo, 2009). It is clear that heme is
involved in many pathways including regulation of heme biosynthesis and catabolism, gene
regulation, iron transport, and reactions of active heme protein intermediates due to H2O2. The
Protein Data Bank (PDB) currently contains approximately 2400 proteins with at least one heme
moiety, a substantial increase from approximately 1000 proteins in 2004 (Reedy & Gibney,
2004). However, if the protein structure is unknown, prediction of the heme binding site is
challenging. A heme serving as an affinity label would be a significant tool in determining the
binding site of this prosthetic group. Our aim was to develop a heme affinity label that could be
covalently attached to the protein via an amide linker between a heme propionate and a lysine of
the protein. The strategy involved initial heme modification by N-hydroxysuccinimide (NHS),
protein reconstitution, and covalent attachment of the heme, followed by peptidase digestion of
the protein and HPLC/MS analysis of the fragments to reveal the residues to which the heme was
linked (Figure 3.1). Human serum albumin (HSA) and myoglobin (Mb) were used as model
proteins in this work.

3.1.1 Heme affinity labels in Mb.

To date, we are aware of two sets of studies on heme affinity labels. Ortiz de Montellano
and co-workers covalently linked hemes to apoMbs via Fe-aryl linkers with two photoaffinity
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probes (Tschirret-Guth et al., 1998; Tschirret-Guth et al., 1999). One approach involved an
azidophenyldiazene (four-step synthesis); the second involved a
trifluoromethyldiazirinphenyldiazene (six-step synthesis). In both cases, the probe was
covalently linked to Mb via irradiation during reconstitution. Tryptic digestion of the labeled
proteins followed by mass spectrometric analysis of the peptides identified the active site
residues. Unfortunately, these affinity labels were not stable to long term storage (P. Ortiz de
Montellano, personal communication to Dr. Dixon). After completion of the project, we became
aware of a much earlier effort. Warme and Hager covalently linked a mesoheme to an apoMb
via an amide linker between a heme propionate and a lysine (Warme & Hager, 1970b; Warme &
Hager, 1970a). The modified mesoheme was prepared by initial formation of mesoheme lithium
chloride salt, followed by dissolution of this salt in SO3/DMF solution and purification of
mesoheme monosulfuric anhydride by extraction. The amide linker was synthesized by
reconstitution of apoMb with mesoheme monosulfuric anhydride (yield 46%). The active site
lysine for covalent linkage was determined to be Lys45 via pepsin digestion followed by
fragments separation and identification via amino acid analyzer.

3.1.2 Reconstitution of proteins with hemes bearing derivatized propionates.

In designing this project it was felt that reconstitution with a mixture of hemin, its two
mono-esters (derivatization at the 6- and 7- positions) and the diester would be the first step. If
the covalent attachment were to occur in high yield, the components of the mixture could be
separated, if necessary, in a further refinement of the protocol.
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For this approach to be successful, it was important that hemin with derivatization at
either one or both propionates would still reconstitute into the protein. Literature reports gave us
confidence that this would be the case. Hemin diester has been successfully used in
reconstitution studies with hemoglobin (O'Hagan, 1960), myoglobin (Tamura et al., 1973;
Krishnamoorthi & La Mar, 1984; Belogortseva et al., 2007), horseradish peroxidase (Tamura et
al., 1972; Makino & Yamazaki, 1972; Adak & Banerjee, 1998), cytochrome b5 (Tamburini &
Schenkman, 1986; Dixon et al., 1990), and cytochrome P450 (Modi et al., 1995). These
previous studies gave us confidence that alterations at the heme propionates would not prevent
binding to the apoprotein. We note however, that myoglobins reconstituted with derivatized
hemes may have reduced thermal stability and higher heme dissociation rates (Hunter et al.,
1997).
It was also the case that the derivatization of heme would not be expected to prevent
binding to albumin. The literature on porphyrin and metalloporphyrin binding to albumin is
extensive. For the purposes of this study, it is useful to note that protoporphyrin and its dimethyl
ester have essentially the same binding constant with albumin (Rinco et al., 2009). This
indicates that modification of the propionates should not interfere with binding of the hemin to
albumin.

3.1.3 Overview of N-hydroxysuccinimide (NHS) as a way of covalently attaching
molecules to proteins.

NHS was chosen to modify heme before heme covalent labeling for this work because
the NHS esters react with amino acid amines to generate amides (Anderson et al., 1964; Lapidot
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et al., 1967; Salmain & Jaouen, 2003), but not with monoesters of phosphoric acid or hydroxyl
groups (Lapidot et al., 1967). This aminoacylation reaction has been introduced to covalent
labeling of proteins (Salmain & Jaouen, 2003). N-Succinimidyl arylacetates reacting with
amines on human serum albumin (HSA) were used to investigate the kinetic acylation process
(Hirata et al., 1991). The NHS porphyrin esters including protoporphyrin NHS-ester (Sakamoto
et al., 2004), mesoporphyrin NHS-ester (Tamura et al., 1973; Obataya et al., 2000), and
tetraphenylporphyrin metal chelate NHS-ester (Roberts et al., 1987; Bedel-Cloutour et al., 1991)
have been reported in the literature. We have chosen this NHS hemin derivative in preference to
other possible ones. Specifically, we believed that the mixed anhydride, COCl and COBr would
be subject to hydrolysis that would be too rapid under the protein condensation conditions.

3.1.4 Overview of human serum albumin.

Human serum albumin (HSA) was chosen as a protein for this study because it binds
heme reversibly at a known site, is stable and readily available, and some data on peptide
hydrolysis are available. HSA is a nonglycosylated 66 kDa protein consisting of 585 amino
acids (Carter & Ho, 1994). It is the most abundant protein in plasma. HSA acts as a carrier of
hemin, participating in the process of heme transfer to liver (Kamal & Behere, 2005). Under
physiological conditions, HSA in plasma (35 – 55 g/l, Kd  1  10-8 M) transiently binds hemin
and then transfers it to hemopexin (0.5 – 1.2 g/l, Kd  1  10-12 M), which has a much higher
binding affinity (Adams & Berman, 1980; Tolosano & Altruda, 2002). Hemopexin then delivers
hemin to liver via a receptor-mediated uptake mechanism.

55
HSA is a heart-shaped protein composed of three homologous domains (I–III), each of
which contains two subdomains (A and B) connected by random coils (He & Carter, 1992).
Hemin is preferentially bound in a D-shaped hydrophobic cavity in subdomain IB of the protein
surface (Wardell et al., 2002; Zunszain et al., 2003). It is five-coordinated to a tyrosine ligand
and has salt bridges between the propionates and amino acids (histidine and lysine).
Three aspects of heme binding to albumin are encouraging in terms of the proposed
experiments. The reversible hemin binding with albumin (Kd = 1  10-8 M, pH 7 and 24 oC)
(Adams & Berman, 1980) indicates that the hemin binding is fairly loose and thus there are
opportunities for nucleophilic attack of proteins on NHS modified hemin. The short distance
between Lys190 and hemin propionate side chains (less than 5 Å) also suggests the possibility of
covalent linkages. The configurational flexibility of HSA might also make covalent attachment
easier (Baroni et al., 2001; Fanali et al., 2007).

3.1.5 Overview of myoglobin.

We chose myoglobin because it is widely studied (Vojtechovsky et al., 1999; Wittenberg
& Wittenberg, 2003), stable, relatively inexpensive, and as outlined above, has been
reconstituted with hemin dimethyl esters (Tamura et al., 1973; Krishnamoorthi & La Mar, 1984;
Belogortseva et al., 2007). Myoglobin (Mb), with the sequence length of 154 amino acids and a
molecular weight of 16700 Da (Ordway & Garry, 2004), is a single-chain globular protein. It
was the first protein with a three-dimensional structure determined by X-ray crystallography
(Kendrew et al., 1958). It has eight alpha helices and a hydrophobic heme binding site in which
heme is coordinated by a histidine residue (Watson & Andrew, 1969).
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3.1.6 Determination of covalently linked hemes by HPLC/MS.

Literature studies have shown that peptidase digestion followed by MS or HPLC/MS
could reveal the attachment point of a heme covalently bound to a protein. This approach has
been used to investigate cytochrome P4504A, in which the heme is covalently linked protein at
Glu318 (Hoch & Ortiz de Montellano, 2001; Ortiz de Montellano, 2008). The approach was also
used to study a selenocysteine mutation of human heme oxygenase-1 which has a covalently
linked heme (Jiang et al., 2009). In studies of ascorbate peroxidase and cytochrome c peroxidase,
exposure of the holoproteins to peroxide led to formation of a heme covalent linkage (Metcalfe
et al., 2007; Pipirou et al., 2007). In addition, a heme covalently bound in cytochrome b6 from
Chlamydomonas reinhardtii was studied by Lys-C digestion followed by MALDI analyses (de
Vitry et al., 2004).
After peptidase digestion of these heme linked proteins, the generated peptide fragments
are analyzed in three ways: direct MS measurement, HPLC/MS, or concentration of the heme
linked fragments via HPLC followed by MS. Raven and co-workers analyzed the digested
ascorbate peroxidase fragments via either direct MALDI or HPLC concentration followed by
MALDI/MS/MS analyses (Metcalfe et al., 2007; Pipirou et al., 2007). Ortiz de Montellano and
co-workers analyzed the digested myoglobin, cytochrome P4504A, and human heme oxygenase1 by HPLC/MS, using MALDI (Tschirret-Guth et al., 1998), ESI-MS (Hoch & Ortiz de
Montellano, 2001), and MALDI/MS/MS (Jiang et al., 2009), respectively.
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3.1.7 Glutamyl endopeptidase (staphylococcal peptidase I) (Glu-C) as the digested enzyme
for HSA and Mb.

We chose glutamyl endopeptidase (staphylococcal peptidase I) (Glu-C) as the protease.
This decision was based both on the expected binding site of the heme and on mass spectrometry
considerations. We predicted that the heme would most likely attach to Lys190 in HSA. Lys190
is located on the surface of the known heme binding pocket (Figure 3.2A) (Wardell et al., 2002),
where it is possible for active-site hemin to be in contact with the side chains of this amino acid.
In the HSA-heme structure solved by Wardell et al., the distance between the –NH2 group of
Lys190 and the nearby propionate groups is 3 – 5 Å (Wardell et al., 2002). We considered a
number of commercially available peptidases (approximate 40 enzymes) using PeptideCutter
Tool from ExPASy (Gasteiger et al., 2005). Upon HSA digestion by Glu-C, the predicted
hemin-attached fragment is of 20 amino acids (aa 189-208, GKASSAKQRLKCASLQKFGE).
MALDI assignment of peptide sequences is most successful if the fragments are 8 – 18 amino
acids in length. Glu-C was chosen as the protease for HSA. The rest proteases were not
considered because the predicted hemin-attached fragments were either too short or too long for
MALDI measurement.
Glu-C was chosen for Mb for the same reasons for HSA. Lys45 and Lys96, located in
the active site, appear to be in the correct position (Maurus et al., 1997; Cavallaro et al., 2008) to
link hemin via an amide bond (Figure 3.2B). The distance between –NH2 of Lys45 and the
nearby propionate group is approximately 3 Å, and the distance between –NH2 of Lys96 and the
nearby propionate group is approximately 7 Å. The length of these two lysine containing
fragments, aa 42-52 and 86-105, falls into a reasonable range for MS detection (Table 3.1).
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3.2

Experimental section.

3.2.1 Synthesis of N-hydroxysuccinimide monoester of hemin (hemin NHS-monoester).

In our hands, the published procedures for NHS esters of tetrapyrroles (Tamura et al.,
1973; Roberts et al., 1987; Bedel-Cloutour et al., 1991; Obataya et al., 2000; Sakamoto et al.,
2004) gave only moderate yields. To optimize the reaction conditions, two alternative reagents
for the coupling [thionyl chloride and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC)],
two solvents (DMF and CH2Cl2), as well as different reagent ratios and reaction times were tried
(Table 3.2). We found experimentally that EDAC hydrolyzed in aqueous buffer with a half-life
of approximately 2 h. Thus, thionyl chloride was used instead. The esterification reaction was
monitored via TLC with a developing solution of 0.5/9.0/0.5 MeOH/CH2Cl2/pyridine for the
final reaction mixture of hemin modification. The optimized conditions were hemin and thionyl
chloride (molar ratio 1:200) allowed to react in DMF under argon in the dark at 65 oC for 2 h,
followed by sequential addition of NHS solution (200 eq in CH2Cl2/DMF) and triethylamine
(200 eq) at 4 oC. The entire mixture was reheated under argon in the dark at 65 oC for 19 h. The
TLC plate showed that more than 50% of the hemin was converted into esters.

3.2.2 Trial purification of hemin-NHS reaction product.

To determine useful HPLC conditions, hemin and hemin dimethyl ester were separated
via a high-performance liquid chromatography (HPLC) reverse phase column (ZORBAX Eclipse
XDB-C18, 4.6 × 50 mm, observation at 410 nm). Solvent A [3:2 volume ratio of phosphate
buffer (0.1 M, pH 3.5) in MeOH] and solvent B (MeOH) were used as eluents. With 30% B
gradient to 100% B over 10 min, hemin was eluted at 9.3 min and hemin dimethyl ester at 10.9
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min. These elution conditions were used to separate a reaction in which EDAC was used as the
coupling agent. There were three product peaks, with elution times of 9.3 min for the unreacted
hemin, 9.9 min (assigned the hemin NHS-monoester), and 11.5 min (assigned the hemin NHSdiester). The corresponding peak area ratio was 25:5:1. It was felt that the HPLC elution times
of the hemin and the monoester were too close for preparative separation. It was also noted that
the monoester would be a mixture of the 6- and 7-isomers, and the reaction of either of these (or
the diester), followed by expected hydrolysis of the second ester during the protease cleavage
protocol) would all finally give the desired covalently bound heme. Therefore, in subsequent
studies, a hemin-thionyl chloride-NHS product (mixture of hemin, hemin monoester and diester)
was used in protein reconstitution without further purification.

3.2.3 Reconstitution of HSA and apoMb.

The hemin-thionyl chloride-NHS product mixture (2 eq heme) was diluted to ~1.0 M by
DMF and added to the solution of commercial HSA (50 M in pH 8.2, 20 mM aqueous
phosphate buffer, 1 eq) at rt in dark. The volume ratio of DMF to aqueous buffer was kept at
1:10. After gently stirring for 24 h, the protein mixture was dried under vacuum and treated via
2-butanone/acid method to remove hemin that was not covalently bound (Asakura, 1978).
An attempt was made to separate HSA and hemin-linked HSA on a reverse phase HPLC
column (ZORBAX S300 C8, 4.6  150 mm, 3.5 m) with solvent A (0.1% HCOOH in water,
v/v) and solvent B (0.1% HCOOH in MeCN, v/v). Various elution protocols were tried, but
there was only one peak, with spectral analysis at 280 and 410 nm overlapping. Thus, this
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column did not separate the mixture. This HSA reconstituted product was then used directly in
digestion experiments without further purification.
ApoMb was prepared according to the literature (Asakura, 1978). The reconstitution of
Mb was done using the same procedure as described above for HSA.

3.2.4 Glu-C digestion of the commercial and reconstituted HSA.

Standard digestion tests on commercial HSA were run under nonreducing nondenatured
conditions (Kouzuma et al., 2002), reducing nondenatured conditions (Bruce et al., 1999), and
reducing denatured conditions (Wa et al., 2006) similar to those described in the literature. To
optimize the digestion process of HSA, treatment of commercial HSA with and without sodium
dodecyl sulfate (SDS) denaturation, with and without dithiothreitol (DTT) and iodoacetamide
(IA), and different Glu-C digestion time lengths were tried (Table 3.3). SDS unfolds proteins by
disrupting non-covalent bonds. DTT breaks the –S–S– bond between cysteines. IA is used to
bind covalently to the –SH side chain of cysteine so the protein cannot form –S–S– bonds. The
digested product was monitored by SDS-PAGE. In the optimized protocol, all the reagents were
dissolved in NH4HCO3 aqueous buffer (pH 7.9, 100 mM). HSA (800 g/ml, 500 l) was mixed
with SDS solution (1% of w/v, 100 l) and incubated at 55 oC for 60 min. To this mixture DTT
(50 mM, 100 l) was added and incubated at 55 oC for 60 min. IA (50 mM, 210 l) was added,
and the mixture was incubated for another 60 min at rt in dark. This protein mixture was filtered
via a filter device during centrifugation to remove small molecules in the system. The volume of
the purified protein was adjusted to 500 l by NH4HCO3 buffer. The purified protein was mixed
with Glu-C (16 g/ml, 500 l) and incubated at 37 oC for 16 h. The digestion was terminated by
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adding 10 l concentrated HOAc. These digested protein fragments were frozen immediately at
–80 oC, lyophilized, and cleaned by C18 Ziptip for MALDI measurement.
Reconstituted HSA was digested by Glu-C using the same procedure as for commercial
HSA.

3.2.5 UV-visible spectroscopy.

The UV-visible spectra of the reconstituted HSA and Mb products were recorded [Varian
50 Bio spectrophotometer, 1.5 mL quartz Supracil cuvettes (Spectracell) with 1 cm path lengths].
The yield of reconstituted Mb was predicted using the extinction coefficients of apoMb (15.47
mM-1cm-1) and holoMb (ε280/holoMb = 34.4 mM-1cm-1, ε408/holoMb = 188 mM-1cm-1) (Tamura et al.,
1973; Pace et al., 1995).

3.2.6 Mass spectroscopy.

The digested commercial HSA, the reconstituted HSA product, and the digested
reconstituted HSA were each subjected to matrix-assisted laser desorption/ionization mass
spectrometry (MALDI) using an ABI 4800 MALDI TOF-TOF analyzer (MALDI TOF-TOF).
The digested reconstituted HSA was also analyzed by HPLC/ESI-MS (AB SCIEX API 3200TM
LC/MS/MS triple quadrupole mass spectrometer equipped with an orthogonal Turbo ion spray
source and Agilent 1200 Series HPLC System). HPLC was run with 5% solvent B (0.1%
HCOOH in MeCN, v/v) gradient to 100% solvent A (0.1% HCOOH in water, v/v) over 60 min.
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3.3

Results and discussion.

3.3.1 Covalent attachment of hemin to HSA.

The hemin NHS ester successfully reconstituted into apoHSA and reacted with it to give
a product with covalently linked hemin as shown by two lines of evidence. First, the UV-visible
spectrum of the HSA product after removal of unbound hemin showed bands at 280 nm and 406
nm (Figure 3.3A). The absorbance at 406 nm was due to hemin. Because noncovalently linked
hemin was removed before the UV-visible measurement, the hemin is presumed to be covalently
bound to HSA. Second, the observed molecular weight (MW) of the reconstituted HSA mixture
was 67078 Da; the theoretical MW of intact HSA is 66478 Da. This difference of 600 indicates
that heme is bound (heme has a molecular weight of 615 Da; the MALDI error is expected to be
about 0.3%).

3.3.2 Peptidase cleavage of commercial HSA and reconstituted HSA (HSA-hemin).

In the MALDI measurement of Glu-C digested commercial HSA, fifteen fragments were
assigned via MALDI (Table 3.4). The fragment comprised of amino acids 189-208, predicted to
have covalently linked hemin, was observed at 2195.0 Da (Figure 3.4).
Next, MALDI of the cleaned and digested HSA-hemin fragments was performed. The
MALDI did not show a peak corresponding to the hemin bound fragment aa 189-208. This is
presumably due to the low yield of covalently linked hemin.
An HPLC/MS separation of the same sample showed many peaks including undigested
HSA. The undigested HSA had absorbance at 410 nm, but absorbance at this wavelength for the
digested fragments was minimal. The lack of significant 410 nm absorbance for the digested
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protein fragments indicated that this approach was unlikely to be successful without significantly
more development of the procedure.

3.3.3 Covalently attachment of hemin to apoMb.

The reconstitution and the covalent attachment to apoMb were both successful. The UVvisible spectrum of the Mb product after removal of unbound hemin shows bands at 280 nm and
408 nm in the ratio of 4.2:1 (Figure 3.3B). The absorbance at 408 nm indicates that the hemin is
covalently linked. We estimate that approximately 2% of the myoglobin has hemin covalently
attached (ε280/apoMb = 15.47 mM-1cm-1, ε280/holoMb = 34.4 mM-1cm-1, ε408/holoMb = 188 mM-1cm-1)
(Tamura et al., 1973; Pace et al., 1995).

3.3.4 Peptidase cleavage of reconstituted holoMb (Mb-hemin).

Although it was clear that we were able to covalently attach hemin to myoglobin, the low
yields of the adduct, the difficulty of HPLC separation, and the difficulty of MALDI sequence
assignment on long peptides all led us to consider the future of this approach. Our experience
would indicate that this approach needs considerable amounts of protein, and a single site of
heme attachment which upon peptidase cleavage gives a short peptide. However, as these
conditions will in general not be fulfilled with a novel heme protein, further experiments were
not pursued.
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Figure 3.1 Flowchart of heme labeling of proteins.
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Figure 3.2 (A) The active site of HSA (PDB ID 1N5U); Lys190 is in blue; (B) The active site of
Mb (1WLA); Lys45 and Lys96 are in blue.

66

A 1.2

HSA-hemin
apoHSA

Absorbance

0.9
0.6
0.3
0.0
250

400

550

700

Wavelength (nm)

B

1.2
Mb-hemin
commercial Mb

Absorbance

0.9

apoMb

0.6

0.3

0.0
250

400

550

700

Wavelength (nm)

Figure 3.3 Normalized UV-visible absorbance spectra in phosphate buffer (20 mM, pH 8.2). (A)
apoHSA and HSA with covalently linked hemin; (B) apoMb, commercial Mb, and Mb with
covalently linked hemin. In both cases, unbound hemin has been removed from the protein
sample via 2-butanone/acid method (Asakura, 1978).
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Figure 3.4 MALDI spectrum of Glu-C digested commercial HSA. The sample was analyzed
using an ABI 4800 MALDI TOF/TOF Analyzer in positive ion mode. The matrix was prepared
with 10 mg/ml sinipinic acid, 30% acetonitrile and 0.1% trifluoroacetic acid.
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Table 3.1 The predicted heme-containing fragments of Mb after cleavage by Glu-C. (The
potential K attached to hemin is highlighted in yellow.)
Fragment position
aa 42-52
aa 86-105

amino acid sequence
KFDKFKHLKTE
LKPLAQSHATKHKIPIKYLE
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Table 3.2 Reaction conditions of hemin modification by NHS.
reagent
Hemin/EDAC/NHS
Hemin/EDAC/NHS
Hemin/EDAC/NHS

ratio
1:1.1:1.1
1:10:10
1:100:10

solvent
aqueous
aqueous
aqueous

Hemin/SOCl2/NHS
Hemin/SOCl2/NHS
Hemin/SOCl2/NHS
Hemin/SOCl2/NHS/TEA

1:10:10
1:50:50
1:200:100
1:200:200:200

DMF
DMF
CH2Cl2/DMF
CH2Cl2/DMF

Notes
Different time lengths

Trial removal of excess
SOCl2
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Table 3.3 Optimization of Intact HSA digestion by Glu-C. (A) nonreducing condition; (B) reducing condition; (C) denaturing
condition.
(A) Nonreducing condition
Sample No.
Glu-C/HSA (w/w)
DTT/HSA (M/M)

I
2/100
0

II
2/100
0

IA/HSA (M/M)
SDS/HSA (w/w)
Digestion time (h)
Digestion temp. (oC)
ZipTip cleaning

0
0
6
37
No

0
0
24
37
No

(B) Reducing condition
Sample No.
Glu-C/HSA (w/w)
DTT/HSA (M/M)
IA/HSA (M/M)
SDS/HSA (w/w)
Digestion time (h)

I
2/100
100/2
100/2
0
2

II
2/100
100/2
100/2
0
4

III
2/100
100/2
100/2
0
6

IV
2/100
100/2
100/2
0
8

V
2/100
100/2
100/2
0
16

VI
2/100
100/2
100/2
0
16

Digestion temp. (oC)
ZipTip cleaning

37
No

37
No

37
No

37
No

37
No

37
Yes
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(C) Denaturing condition
sample No.
Glu-C/HSA (w/w)
DTT/HSA (M/M)
IA/HSA (M/M)
SDS/HSA (w/w)

I
2/100
0
0
80/100

II
2/100
0
0
80/100

III
2/100
0
0
80/100

IV
2/100
100/2
100/2
80/100

V
2/100
100/2
100/2
80/100

VI
25/1 (molar ratio)
100/2
100/2
heat denaturation

Digestion time (h)
Digestion temp. (oC)
ZipTip cleaning

24
4
No

24
37
No

8d
37
No

16
37
Yes

25
37
Yes

16
37
Yes
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Table 3.4 Assigned amino acid fragments of commercial HSA from MALDI.
Assigned aa.
7-17
101-119
142-153
154-167
189-208
209-227
231-244

MW observed (Da)
1300.8
2291.2
1519.8
1705.0
2195.0
2261.9
1569.0

MW calculated (Da)
1300.7
2291.2
1519.8
1704.9
2194.2
2232.6
1569.6

Note
Correct peak
Cys alkylation missed
Correct peak
Correct peak
Correct peak
with K+
Correct peak

322-333

1454.7

1432.7

with Na+

369-376
377-393
401-425
451-465
521-531
543-556
572-585

1031.6
2029.0
2922.6
1800.9
1313.8
1583.7
1326.8

1031.5
2029
2922.6
1801.9
1313.8
1583.8
1326.8

Correct peak
Cys alkylation missed
Correct peak
Correct peak
Correct peak
Correct peak
Correct peak
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4

4.1

Heme Binding and Uptake in Streptococcus pyogenes

Introduction.

4.1.1 Iron in bacteria.

Iron is an essential element for most organisms, including the majority of bacteria
(Wandersman & Delepelaire, 2004; Krewulak & Vogel, 2008; Hider & Kong, 2010). It
participates in a wide range of metabolic and signaling processes, including oxygen transport via
heme in hemoglobin, and electron transfer and redox reactions during respiration and
photosynthesis. However, free iron is biologically unavailable at micromolar concentration
levels. Fe(III) hydroxide is insoluble (ksp  10-39); Fe(II) reacts with H2O2 producing toxic
hydroxyl radicals (–OH• ) via the Fenton reaction, resulting in oxidative damage of cellular
lipids and DNA (Krewulak & Vogel, 2008; Hider & Kong, 2010). Iron sequestration is achieved
by iron storage predominantly in heme and to some extent in other high-affinity iron-binding
transport proteins such as transferrin, lactoferrin and ferritins (Wandersman & Delepelaire, 2004).
Pathogenic bacteria acquire iron from the host proteins transferrin and lactoferrin, heme,
and iron chelator siderophore (Crosa et al., 2004; Heinrichs et al., 2004; Wandersman &
Delepelaire, 2004; Krewulak & Vogel, 2008; Hider & Kong, 2010). Since approximately 95%
of iron within the host is stored in the form of heme, primarily as hemoglobin (Otto et al., 1992),
heme is a major source of iron for bacteria (Crosa et al., 2004; Heinrichs et al., 2004;
Wandersman & Delepelaire, 2004).
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4.1.2 Heme uptake pathways in bacteria.

Heme can be acquired through biosynthesis, uptake or via both pathways in bacteria
(Wilks & Burkhard, 2007; Cavallaro et al., 2008; Tong & Guo, 2009). Cavallaro et al. reported
in 2008 that among 406 prokaryotic organisms, 41% of the bacteria could only synthesize heme,
5% could only take up heme from external source, and 54% could perform both processes
(Cavallaro et al., 2008). These conclusions were based on gene sequence analysis of the proteins
involved in heme biosynthesis and uptake.
Most studies on bacterial heme uptake have focused on Gram-negative bacteria (Cescau
et al., 2007; Wilks & Burkhard, 2007; Tong & Guo, 2009). Heme or hemoproteins (e.g.,
hemopexin, hemoglobin, hemoglobin-haptoglobin) are first bound to bacterial cell surface
receptors; the heme is then transferred into cytoplasm via ABC (ATP-binding cassette)
transporters. In the extracellular medium of some Gram-negative bacteria, hemophores scavenge
heme from hemoproteins and transfer heme to the cell surface receptors (Cescau et al., 2007).
The heme uptake in Gram-positive bacteria has also been studied (Wilks & Burkhard,
2007; Tong & Guo, 2009). Similar heme transfer through cell surface receptors and ABC
transporters are found in Corynebacterium diphtheriae, Staphylococcus aureus, and
Streptococcus pyogenes.
After heme is transferred into the cytosol, iron is extracted by heme oxygenase (Wilks &
Burkhard, 2007; Tong & Guo, 2009) or reverse ferrochelatases (Létofféet al., 2009). Heme
oxygenase liberates free iron through degradation of the tetrapyrrole ring into α-biliverdin with
the assistance of NADPH and O2, and the release of CO (Maines, 1997).
Iron extraction from heme without disrupting the tetrapyrrole ring, e.g., reverse
ferrochelatase activity, was first reported in 2009 (Létofféet al., 2009). Létofféet al. identified
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two heme degrading enzymes in E. coli K12, YfeX and EfeB. After screening a genomic library,
colonies were found giving a bright red fluorescent under near-UV light irradiation (405 nm),
which indicated porphyrins in these colonies. These were shown to have either the YfeX or
EfeB gene. Addition of heme or mesoheme to the cell culture producing YfeX and EfeB
respectively resulted in accumulation of protoporphyrin IX (PPIX) or mesoporphyrin IX
(MPPIX) as a function of incubation time.
EfeB and YfeX belong to the family of dye-decolorizing peroxidases and are located in
the cytoplasm and periplasm, respectively (Blattner et al., 1997; Sturm et al., 2006). There are
three available crystal structures of EfeB from E. coli K12, apo-EfeB (PDB ID 2Y4D), PPIXEfeB (2Y4E), and heme-EfeB (2Y4F). The protein is a homodimer, with one PPIX or heme in
each subunit. PPIX and heme are bound in the same orientation. Heme is five-coordinate with
histidine as the axial ligand. Sequence alignment via BLAST in our laboratory shows that YfeX
and EfeB share ~25% identities, with the axial ligand histidine in YfeX conserved in EfeB
(Figure 4.1).

4.1.3 Streptococcus pyogenes.

S. pyogenes (Group A streptococcus, GAS) is a fermentative, nonmotile, Gram-positive
coccus which occurs in chains or in pairs of cells. It is one of the most frequent pathogens in
humans. Carapetis et al. reported in 2005 that S. pyogenes had caused 18.1 million severe
disease cases, with 1.78 million new cases and at least 517,000 deaths each year (Carapetis et al.,
2005). Infections mostly start from the throat or skin, but are not limited to those places. The
resulting diseases range from mild infections, e.g., strep throat, scarlet fever, and impetigo, to
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life-threatening infections, e.g., sepsis, necrotizing fasciitis, and streptococcal toxic shock
syndrome (Bullen et al., 1999; Stevens, 2001; Musser & Krauss, 2005; Backx & Healy, 2008).
In the past decade, S. pyogenes has been found increasingly resistant to antibiotics (e.g.,
tetlithromycin and erythromycin) in medical settings around the world (Canton et al., 2002;
Albrich et al., 2004; Ardanuy et al., 2010). This decrease in the susceptibility of S. pyogenes to
those macrolides potentially poses significant risks for infected populations. Since heme uptake
from the host environment is the only iron acquisition pathway in S. pyogenes (Eichenbaum et al.,
1996b; Eichenbaum et al., 1996a; Montañez et al., 2005), new antibiotics based on inhibition of
this pathway might be developed reduce the severity of S. pyogenes infections. Because humans
synthesize their own heme (Litwack, 2008), this approach might have reduced side effects in a
clinical setting.
The heme uptake systems in S. pyogenes involves two cell surface heme binding proteins,
Shr (streptococcal hemoprotein receptor) (Bates et al., 2003; Zhu et al., 2008a) and Shp
(streptococcal cell surface protein) (Lei et al., 2002; Aranda et al., 2007), and an ABC (ATPbinding cassette) heme transporter which is comprised of the heme-binding lipoprotein SiaA
(streptococcal iron acquisition protein A) (HtsA, heme transporter of group A streptococcus)
(Lei et al., 2003; Bates et al., 2003; Sook et al., 2008; Sun et al., 2010; Ran et al., 2010), the
permease SiaB (HtsB), and the ATPase SiaC (HtsC). Shr can acquire heme from hemoglobin
(Ouattara et al., 2010) and then transfer this heme to Shp (Zhu et al., 2008a); Shp then relays its
heme to SiaA to across the bacterial envelope (Liu & Lei, 2005; Nygaard et al., 2006; Ran et al.,
2007). Shp has been characterized by X-ray crystallography (PDB ID 2Q7A) (Aranda et al.,
2007). The heme is six-coordinate with two methionines (discussed in more detail below). SiaA
has also been well characterized (Lei et al., 2003; Bates et al., 2003; Sook et al., 2008; Sun et al.,
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2010; Ran et al., 2010). Magnetic circular dichroism (MCD), nuclear magnetic resonance
(NMR), and resonance Raman (rR) analyses suggest that the heme in SiaA is low-spin sixcoordinate with histidine and methionine as axial ligands.

4.1.4 NEAT domain.

The NEAT (near transporter) domains were first identified as conserved region of about
125 amino acids involved in iron uptake via bioinformatics tools (Andrade et al., 2002). They
are folded in the shape of eight-stranded -sandwich, and anchored to the extracellular side of
cell membrane in Gram-positive bacteria (Cavallaro et al., 2008; Grigg et al., 2010). Proteins
may have multiple NEAT domains in diverse architectures. This domain mostly appears close to
the N-terminus, in some cases connected to another NEAT domain via a leucine rich repeat
(LRR). LRR domains are comprised of α helices connected by loops (Kobe & Kajava, 2001).
This domain is mostly involved in protein-protein interactions.
The most detailed studies of NEAT domains have been those in conjunction with an ABC
heme transporter in Staphylococcus aureus (Mazmanian et al., 2003; Maresso & Schneewind,
2006; Muryoi et al., 2008; Tiedemann et al., 2008; Zhu et al., 2008b; Grigg et al., 2010). NEAT
domains are found in four proteins in this Isd (iron-responsive surface determinant) system:
IsdA (one NEAT domain) (Vermeiren et al., 2006; Grigg et al., 2007b; Liu et al., 2008b; Pluym
et al., 2008), IsdB (two NEAT domains) (Torres et al., 2006; Tiedemann et al., 2009), and IsdH
(HarA, three NEAT domains) (Dryla et al., 2003; Pilpa & Clubb, 2005; Pilpa et al., 2009), all of
which are cell surface receptor proteins, and in IsdC (one NEAT domain) (Sharp et al., 2007;
Pluym et al., 2008) which is anchored deep in the cell wall. Each Isd protein encodes a secretion
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signal at the N-terminus, NEAT domain(s) in the middle, and a sortase recognition signal near
the C-terminus. X-ray structures of NEAT domains with bound hemes are available for IsdA
(Grigg et al., 2007b), IsdC (Sharp et al., 2007), and IsdHN3 (Watanabe et al., 2008) (Table 4.1).
The NMR structure of IsdHN1 is that of the apoprotein (Pilpa et al., 2006), consistent with an in
vivo role which is thought to involve binding hemoglobin rather than heme (Dryla et al., 2007).
Heme is located in a hydrophobic pocket in the S. aureus NEAT domains. Several
interactions between heme and the binding pocket are conserved. The heme-containing crystal
structures show five-coordinated hemes with a YxxxY pattern, in which the first tyrosine serves
as an axial ligand with Fe-O distances of 2.1–2.2 Å. The second tyrosine is hydrogen bonded to
the first and interacts with the heme pyrrole ring via π-π stacking (Grigg et al., 2007b; Sharp et
al., 2007; Watanabe et al., 2008). Other conserved residues are a serine and another hydrophilic
residue (lysine or glutamine) which form H-bonds with a heme propionate (Grigg et al., 2010).
Sequence alignment of all NEAT domains from Isd system shows that the tryptophan buried
inside the binding pocket which is next to the vinyl end of heme is also highly conserved (Grigg
et al., 2010).
Watanabe et al. found IsdHN3 as a multimeric complex in solution (Watanabe et al.,
2008). They performed size exclusion chromatography (SEC) on different heme loadings of this
domain (0:1 to 2:1) to examine the multimerization state. When the ratio of heme to IsdHN3
was 0:1, there was only one peak, eluting as a monomer (16 kDa); when the ratio was increased
to 1:1, there were two additional peaks eluting before the monomer, corresponding to the
multimer and dimer. When the ratio was increased to 2:1, the multimer peak became the
majority of the species observed, the dimer peak disappeared, and the monomer peak was very
small. Analytical ultracentrifugation on the multimeric elution from SEC showed a broad
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distribution of the molecular weight with the majority at 64 kDa (tetramer) and 98 kDa
(multimer). These observations indicated that the multimerization of IsdHN3 was associated
with heme binding, and that the protein multimerization was in dynamic equilibrium.
Recently, the NEAT domains in Bacillus anthracis (the causative agent of anthrax) have
been the focus of study (Honsa & Maresso, 2011). B. anthracis has four proteins containing the
NEAT domain for heme acquisition. IsdC, IsdX1 (IsdJ), and IsdX2 (IsdK) have one, one, and
five NEAT domains respectively. These domains share less than 40% sequence identity with
known S. aureus NEAT (Gat et al., 2008). A fourth protein in B. anthracis, S-layer homology
(SLH) protein K (BslK), contains three SLH domains and one NEAT domain (Tarlovsky et al.,
2010). It serves as a possible surface protein in anthrax and a heme transporter to IsdC.
In S. pyogenes there is only one protein with a NEAT domain, Shr (streptococcal
hemoprotein receptor) (Bates et al., 2003; Zhu et al., 2008a). Shr contains two domains with the
NEAT architecture, NEAT1 (nearer the N-terminus) and NEAT2. Both domains can bind heme
(Ouattara et al., 2010). Shr is a large protein of 1275 amino acids (Zhu et al., 2008a); the NEAT
domains (~125 amino acids) are thus each only about 10% of the total protein. The two NEAT
domains are separated by an EF-hand motif and a leucine rich repeat region. Shr has a signal
region in the N terminus and two domains of unknown function (DUF1533) preceding the first
NEAT1. The C terminus of the protein has a hydrophobic segment with a positively charged tail;
this presumably serves to anchor the protein to the cytoplasmic membrane. Shr, which spans the
cell wall, has been shown to be exposed to the extracellular environment (Fisher et al., 2008).
Null mutants have been shown to have attenuated virulence in a zebrafish model, indicating the
possible role of this protein in pathogenicity.
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Sequence alignment of the NEAT domains using ClustalW2 indicates different possible
heme axial ligands in S. pyogenes compared to those in S. aureus. Figure 4.2 shows an
alignment of IsdC, IsdX2N1, and BslK from B. anthracis, IsdA, IsdBN2, IsdC, and IsdHN3 from
S. aureus, and Shp, ShrNEAT1, and ShrNEAT2 from S. pyogenes. All of these NEAT domains
except those from S. pyogenes have two conserved tyrosines in the heme binding region. This
implies that B. anthracis NEAT domains have heme five-coordinated to tyrosine, as do the
known domains in S. aureus. In contrast, ShrNEAT1 shows only one aligned tyrosine,
corresponding to the first tyrosine of the YxxxY pattern, with threonine in the position of the
second tyrosine. Thus, ShrNEAT1 may have a different ligand(s) to the heme in comparison to
the three known heme binding NEAT domains of S. aureus. The alignment shows that Met107
of ShrNEAT1 is at the sequence position of the C-terminal axial ligand Met153 of Shp.
Alignment of ShrNEAT1 with only the S. aureus Isd proteins and Shp shows that Met22 and
Met107 of ShrNEAT1 align with the axial ligands Met66 and Met153 of Shp, respectively
(Figure 4.3). This alignment raises the possibility of methionines serving as axial ligands in
NEAT1.
Alignment of ShrNEAT2 with all the NEAT domains listed above shows no tyrosine at
either of the positions in the YxxxY pattern. However, the C-terminal Met136 in ShrNEAT2 is
aligned with the C-terminal Met153 (an axial ligand) of Shp. Alignment of ShrNEAT2 with
only the S. aureus Isd NEAT domains and Shp shows that the N-terminal Met26 of ShrNEAT2
is aligned with the N-terminal Met66 (an axial ligand) of Shp. However, in this case, the Cterminal methionines do not align.
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4.1.5 Studies on bis-methionine ligands to heme.

Heme proteins with bis-methionine ligands are relatively rare. The first example
characterized was in bacterioferritin. X-ray structures are available from E. coli (Frolow et al.,
1994; Dautant et al., 1998; van Eerde et al., 2006; Willies et al., 2009; Lawson et al., 2009; Crow
et al., 2009; Wong et al., 2009), Rhodobacter capsulatus (Cobessi et al., 2002), Desulfovibrio
desulfuricans (Macedo et al., 2003), Azotobacter vinelandii (Liu et al., 2004; Swartz et al., 2006),
Mycobacterium smegmatis (Janowski et al., 2008), Brucella melitensis (PDB ID 3FVB),
Pseudomonas aeruginosa (Weeratunga et al., 2010) and Rhodobacter sphaeroides (Nam et al.,
2010). Bacterioferritin is a roughly spherical, hollow shell protein comprised of identical
subunits with ferroxidase sites (two iron atoms). The heme lies between the α-helix bundles
from adjacent subunits with two axial methionine residues from different subunits (Cheesman et
al., 1990; George et al., 1993).
The structure of D. desulfuricans bacterioferritin is available in reduced (PDB ID 1NF4)
and oxidized (PDB ID 1NF6) forms (Macedo et al., 2003) as is the structure of A. vinelandii
(reduced, PDB ID 2FKZ and oxidized, PDB ID 2FL0) (Swartz et al., 2006). The heme binding
pockets in the reduced and oxidized bacterioferritins from both bacteria are the same, with the
Fe-S distance at 2.1 ~ 2.4 Å, and almost identical heme orientations and directions of nearby
residues. In both oxidation states of the D. desulfuricans bacterioferritin heme binding site, Fecoproporphyrin is six-coordinate with two Met57 from adjacent monomers. The propionate side
chains of this porphyrin are hydrogen bonded to Arg, Lys, Ser, and Tyr. In A. vinelandii
bacterioferritin, as can be seen from the X-ray structures of reduced and oxidized forms, the
distances between the oxygen of propionates in heme and the nearby oxygen of Tyr or nitrogen
of Lys are about 4 Å. This distance allows a hydrogen bond. Upon protein reduction, the main
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change is at the ferroxidase site, where the Fe-Fe distance is increased and a histidine ligand to
iron is lost.
BisMet ligation to heme iron has also been studied in mutants of cytochrome b562 (Barker
et al., 1996b). The H102M mutant has bisMet ligation in the reduced state; in the high-spin
oxidized state, the spectra indicate that only one of the methionines is coordinated to the heme.
The R98C/H102M double mutant, in which the heme is covalently attached to the protein
through a c-type thioether linkage, shows bisMet ligation in the reduced state. In the oxidized
state, the spin state and coordination mode are pH dependant. At acidic pH, R98C/H102M is
low-spin with bis-Met ligands; at basic pH, R98C/H102M is high-spin with a single Met ligand.
More recently, Shp from S. pyogenes has been shown to be a bis-methionine protein
(Aranda et al., 2007). Shp is a dimer with one heme per subunit and two stacked hemes at the
interface between two subunits. Each monomer is an immunoglobulin-like β-sandwich
containing eight β-strands and one α-helix. The heme is bound in a hydrophobic pocket between
the α-helix and two β-strands at C-terminus. The axial ligands to the heme are two methionine
residues, M66 and M153, both from the same subunit. This structural fold is also found in the
heme-binding NEAT domains such as IsdA, IsdC, and IsdH of S. aureus (Grigg et al., 2010).
The propionate side chains are solvent exposed. One is hydrogen bonded to a nearby arginine
and the other is coordinated to the iron center of the exogenous heme.
Ran et al. have studied the heme binding kinetics of wild-type Shp, and the mutant M66A
and M153A mutants (Ran et al., 2007). Heme dissociation was measured by transfer to
H64Y/V68F apomyoglobin. The dissociation rate of M66A was the same as WT, but the
M153A mutant had a rate 700 times faster. Fitting of titration data was interpreted in terms of a
hyperbolic one site binding model with initial complex formation followed by first order iron
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coordination. The calculated coordination rate constants were faster for the mutants than WT
protein, consistent with the necessity to bind two ligands in the latter case. Apparent binding
constants, calculated from the kinetic parameters derived in these experiments, indicated that the
M66A mutant bound heme 3-fold more tightly and the M153A mutant approximately 140-fold
less tightly than WT, indicating the importance of methionine 153 in heme binding. Heme
transfer from Shp to SiaA has been proposed to involve an intermediate with one axial ligand
from each protein.
Electron paramagnetic resonance (EPR) data for heme proteins with bis-Met ligands are
summarized in Table 4.2 and Table 4.3. EPR spectra of bacterioferritins from A. vinelandii, E.
coli, P. aeruginosa and R. sphaeroides are all very similar with a low-spin Fe(III) center showing
g values of approximately 2.86, 2.32, and 1.48 (Cheesman et al., 1992; Watt et al., 1993). Small
amounts of high-spin Fe(III) heme were also seen as signals in the g ≈ 6 region and non-heme
Fe(III) appeared as sharp derivative-shaped signals at g ≈ 4.3. The EPR of wild-type Shp, with
two axial methionines, is largely low spin (Ran et al., 2007). The M66A and M153A mutants
are both high-spin with multiple signals in the g ≈ 6 region.
Magnetic circular dichroism (MCD) data for heme proteins with bis-Met ligands are
summarized in Table 4.4. In early work, magnetic circular dichroism (MCD) spectra for the
bacterioferritins from A. vinelandii, E. coli, and P. aeruginosa all showed a low-spin charge
transfer (CT) band at approximately 2250 nm, taken to be a signature of a bis-Met ligation to the
heme (Cheesman et al., 1990; Cheesman et al., 1992). The tetraphenyl- and octaethyl-porphyrintetrahydrothiophene complexes had bands in the 2100 – 2300 range, consistent with this
assignment (McKnight et al., 1991). The low-spin R98C/H102M mutant of cytochrome b562 had
a band at 2150 nm at pH 4.8 (the protein is bisligated with two methionines at this pH) (Barker et

89
al., 1996b). This band is not observed at pH 9.2, conditions under which one of the methionines
dissociates from the heme.
The porphyrin (π)  ferric (d) MCD CT band is found correlated to the heme axial
ligand(s) (Walker, 1999; Mack et al., 2007; Munro et al., 2009). Beside the bis-Met ligand set,
there are other low-spin bis-ligated hemoproteins with CT bands in a specific range, which are
His-His around 1600 nm and His-Met around 1800 nm (Gadsby & Thomson, 1990; Cheesman et
al., 1993; Spinner et al., 1995; Munro et al., 2009). Low-spin ferric heme with a His-His
coordination has a CT band in the range of 1502 nm (Desulphovibrio vulgaris cytochrome c3, pH
6.5) to 1622 nm (Cytochrome bo from E. coli, pH 7.5) (Gadsby & Thomson, 1990; Cheesman et
al., 1993); low-spin ferric heme with a His-Met coordination has a CT band in the range of 1740
nm (tuna cytochrome c) to 1950 nm (A. uinelandii cytochrome c) (Gadsby & Thomson, 1990;
Spinner et al., 1995).
Redox potential data for heme proteins with bis-Met ligands are summarized in Table 4.5.
Bacterioferritin from A. vinelandii has a redox potential of about -475 mV when the protein is
loaded with iron (Stiefel & Watt, 1979; Watt, 1986) and -225 mV when not loaded (Watt, 1986).
D. desulfuricans, with a bound Fe uroporphyrin, has a redox potential of +140 ±10 mV at pH
7.6 (Romão et al., 2000). The reduced H102M cytochrome b562 mutant has redox potentials of
+420, +300, and +240 mV at pH values of 5.3, 6.2, and 7.0, respectively; the R98C/H102M
mutant of cytochrome b562 has a redox potential of +440 ±5 mV at pH 4.8 (Barker et al., 1996b).
Overall, the limited data available indicate that the redox potential for bis-Met hemes is
dependent on the environmental pH and changes at other binding sites in the heme protein.
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4.2

Experimental section.

4.2.1 Materials and methods for NEAT1.
4.2.1.1 Expression and purification.
The recombinant protein, a gift from Dr. Zehava Eichenbaum, Georgia State University,
were cloned as in frame fusions to both the OmpA leader peptides and the Strep-tag sequence
and expressed from the tet promoter using the IBA pASK-IBA12 expression vector (Ouattara et
al., 2010). The proteins were expressed in Escherichia coli XL1 blue strains grown in a LuriaBertani (LB) medium containing 100 µg/ml ampicillin. Inoculation was done with an overnight
pre-culture and cells were grown at 30°C with shaking at 225 rpm. When the OD600 of the
culture reached 0.5 – 0.6, protein expression was induced by adding anhydrotetracycline to a
final concentration of 200 ng/ml. The culture was incubated overnight at 27°C. Cells were
harvested by centrifugation for 10 min at 8000 rpm at 4°C. The cell pellet was resuspended in
extract solution (20 mM Tris-Cl, 100 mM NaCl, Triton X-100 0.1%). Protease inhibitor (Roche
Complete Mini, EDTA-free) cocktail was added to the cell suspension (1 tablet per liter of
culture), which was then incubated for 30 min on ice. The cell lysed by French press (SIM
AMINCO) for twice. The lysate was centrifuged at 15,000 rpm for 40 min at 4 °C.
The supernate was loaded onto a Strep-Tactin Superflow IBA column, washed with 50
ml buffer A (100 mM Tris-Cl, 150 mM NaCl, 1 mM EDTA, pH 8.0) at 0.5 ml/min, followed by
25 ml buffer B (100 mM Tris-Cl, 150 mM NaCl) at 1.0 ml/min, 1 mM EDTA, 2.5 mM
desthiobiotin, pH 8.0). The fractions with 280 nm absorption were collected and further
analyzed on multimerization by flowing through a Sephacryl S-200 column with the buffer
(sodium phosphate 50 mM, NaCl 150 mM, pH 7.0) at 0.5 ml/min.
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4.2.1.2 Mass spectrometry.
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI) was performed
using an MDS SCIEX 4800 MALDI TOF/TOF Analyzer (Applied Biosystems) MALDI
reflection time-of-flight spectrometer in positive ion mode. The matrix was prepared with 10
mg/ml sinipinic acid, 30% acetonitrile and 0.1% trifluoroacetic acid. The sample solution was
mixed with the matrix solution in a 1:10 ratio and the resulting solution spotted onto the MALDI
plate. Deconvolution of the charge state distribution was performed with the Data Explorer®
software V4.9. Electrospray ionization mass spectrometry (ESI) was performed using a
Micromass Q-TOF Micro mass spectrometer in positive mode. Samples were prepared in a
solution containing 50:50 acetonitrile/water and 0.1% formic acid. The capillary voltage was 3.0
kV, and the flow rate was 5 μL/min. Deconvolution of the charge state distribution was
performed with the MaxEnt program included with the MassLynx software. Throughout the text,
peaks are rounded to the nearest Dalton.

4.2.1.3 Heme reconstitution.
The apo-holo protein mixture obtained from purification was reconstituted in two ways.
In the first experiment, a solution of 6.22 µM hemin in 5 mM NaOH (386 nm = 58.4 mM-1 cm-1)
(Shaklai et al., 1985) was prepared. A solution of 1.0 ml of approximately 100 µM NEAT1
(calculated 280 nm = 38.85 mM-1 cm-1) (Gasteiger et al., 2005) was prepared in phosphate buffer
(100 mM, pH 8.5). The hemin (1.6 eq) was added to the protein solution which was then
incubated at 4 °C for 24 h. Free hemin was removed by a filter unit (Amicon Ultra – 4 30,000
MW Centrifugal Filter Unit) for 3 cycles, 20 min each, at 4 °C with phosphate buffer (100 mM,
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pH 8.5); the recovered protein was purified by FPLC on a Sephadex G25 column (GE Healthcare,
5 ml) with phosphate buffer (100 mM, pH 8.5) at 1.0 ml/min, monitored at 405 nm.
In the second experiment, the hemin solution above (1 eq) was added to NEAT1 (200 µM
in 100 mM, pH 8.0 Tris-Cl buffer). The solution was incubated at 4 °C for 30 min. This
reconstituted protein was run through a Sephadex G25 column on the FPLC with 100 mM, pH
8.0 Tris-Cl buffer at 5.0 ml/min, monitored at 405 nm. The collected fraction was rerun through
a hydrophobic interaction (HIC) FPLC column (Phenyl HP column) at 1.0 ml/min, monitored at
405 nm. The HIC elution was first with 13 ml buffer A (20 mM MES, 1.5 M NaCl, pH 5.0), and
second with linear gradient of 100% buffer A to 100% buffer B (20 mM, pH 5.0, MES) over 50
ml elution volume.

4.2.1.4 Denaturation with guanidinium hydrochloride (GdnCl).
Protein unfolding experiments were performed using GdnCl as the denaturant, according
to standard protocols of Pace (Pace & Scholtz, 1997). The unfolding process was followed by
UV-visible absorption spectrometry [Varian 50 Bio spectrophotometer, 1.5 ml quartz Supracil
cuvettes (Spectracell) with 1 cm path lengths] at 22 °C. In both the oxidized and reduced
NEAT1 unfolding experiments, the GdnCl concentration was 8.32 M (50 mM Tris-Cl, pH 7.0)
measured by refractive index (Pace & Scholtz, 1997); NEAT1 in 50 mM Tris-Cl, pH 7.0 was
used for the titrations. The GdnCl solution was titrated into the protein solution. For Fe(III)
NEAT1, the spectrum at 411 nm was followed until the absorbance changed by less than 0.001
over 5 min, at which point the data was recorded. The times between points were approximately
15 min in the pre-and post-transition regions, and 30 to 125 min in the transition region. The
entire titration took approximately 12 h. Fe(II) NEAT1 was created by removing oxygen via

93
argon flushing for approximately 10 min, followed by adding 6 μL of an anaerobic 0.01 M
sodium dithionite solution (approximately 10-fold excess of reducing agent). During the
anaerobic titrations, the sample was kept under positive argon pressure. The spectrum at 427 nm
was recorded in the same method as for Fe(III) NEAT1. The absorbance as a function of the
concentration of GdnCl was normalized back to the initial concentration and the unfolding curve
was analyzed (Kaleidagraph version 4.01, Synergy Software) using the equation describing a
two-state process (Pace & Scholtz, 1997):

Yabs = {( YF + mF[D]) + (YU + mU[D]) × exp[m × ([D] − [D]½)/RT]}/(1 + exp[m × ([D] −
[D]½)/RT])

where Yabs is the absorbance at any point along the fitted denaturation curve, YF is the
absorbance at of the folded state, YU is the absorbance of the unfolded state, m is the slope at the
midpoint, and also the dependence of the free energy of unfolding on the denaturant
concentration, mF is the slope of the folded state, mU is the slope of the unfolded state, [D] is the
concentration of GdnCl, [D]½ is the concentration of GdnCl at the midpoint of the transition, R is
the gas constant, and T is the temperature (Kelvin). The free energy of protein unfolding in
water [ΔG(H2O)] was calculated as ΔG(H2O) = m[D]½.

4.2.1.5 Thermal denaturation.
Thermal denaturation of NEAT1 was carried out with a UV-visible spectrophotometer
(Cary 50 Bio) which was equipped with a temperature control (TC 125, Quantum Northwest).
Quartz Supracil cuvettes (Spectracell, 1.5 ml) with 1 cm path lengths were used. For Fe(III)
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NEAT1 (~5 M) in sodium phosphate (50 mM, pH 7.5), the spectrum (250 – 800 nm) was
recorded every 2 oC from 20 oC to 60 oC after the sample was equilibrated for 2 min 45 sec at
each temperature. The overall average temperature gradient was about 0.5 oC/min. Right after
60 oC, the sample was re-cooled at 0 oC for 0.5 h and the UV-visible spectrum was retaken.
Fe(II) NEAT1 was prepared by treating Fe(III) NEAT1 (~5 M) in sodium phosphate (50 mM,
pH 7.5) with ~ 20 equivalence of dithiothreitol under Ar. This protein solution was preequilibrated at 20 oC for ~ 2 h. The spectra (250 – 800 nm) as a function of temperature were
recorded in the same way as for Fe(III) NEAT1.
The data were fit to a two-state unfolding model (Swint & Robertson, 1993):
Yabs = {(YF + mFT) + (YU + mUT) exp[ΔHm/R(1/Tm - 1/T)]}/{1 + exp(ΔHm/R(1/Tm - 1/T)]}
Where the ΔHm is the enthalpy of unfolding, Tm is the temperature at which the protein is half
unfolded and the remaining variables are as described above. To simplify the comparison of
thermal denaturation between Fe(II) and F(III) NEAT1, the extent of protein unfolding is
presented as the fraction of folded protein as calculated with the following equation:
Faction folded = [Y - (YU + mUT)]/[(YF + mFT) - (YU + mUT)]

4.2.1.6 Homology modeling.
Homology modeling was used to predict the structure of NEAT1 (residues in green, 1 –
133, in Figure 4.4). The NEAT1 model was constructed using several similar proteins including
IsdC (PDB ID 2K78) (Villareal et al., 2008) and IsdA (PDB ID 2ITF) (Grigg et al., 2007b) as
templates by I-TASSER (Zhang, 2008; Zhang, 2009; Roy et al., 2010). Dynamic simulations of
this initial model used an explicit TIP3P (Jorgensen et al., 1983) water cubic box in the Amber 8
program (Case et al., 2005). The all-atom parm99SB force field parameters (Hornak et al., 2006)
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and the heme all-atom force field parameters (Giammona, 1984) were used. During the
simulation, a 50 ps minimization step with an integration time step of 0.001 ps followed by two
steps with an integration time step of 0.002 ps at 300 K (a 50 ps MD step and a 50 ps
equilibration step) were used to minimize and equilibrate the system in a NTP ensemble to a
pressure of 1 bar (1 bar = 100 kPa) and a temperature of 300 K. Then a 15 ns dynamic
simulation step at 300 K with an integration time step of 0.002 ps was applied. Structures were
visualized in PyMOL (DeLano, 2009) and VMD (Humphrey et al., 1996).

4.2.2 Materials and methods for NEAT2.
4.2.2.1 Expression and Purification.
The recombinant protein is a gift from Dr. Zehava Eichenbaum, Georgia State University.
It was prepared in the same method as for NEAT1.

4.2.2.2 Mass spectrometry.
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI) was performed
on NEAT2 with the same method described on NEAT1.

4.2.2.3 Guanidinium and thermal unfolding.
Guanidinium hydrochloride (GdnCl) denaturation experiments and thermal unfolding of
ferric and ferrous NEAT2 were performed in the same method described above for NEAT1. The
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only difference was the Soret used for fitting. The absorbances at 412 nm for ferric NEAT2 and
at 426.5 nm for ferrous NEAT2 were recorded as functions of the concentration of GdnCl.

4.2.2.4 pH Titration – autooxidation and autoreduction.
To analyze the autooxidation and autoreduction of NEAT2, pH titrations were run with
monitoring by optical spectroscopy. NEAT2 in 20 mM each CAPS, MES, and Tris-Cl was
treated with small aliquots of 1.0 M HCl or 1.0 M NaOH over a pH range of 6.5~10.5. At each
pH point, the solution was held until it reached equilibrium, e.g., until ASoret changed by less
than 0.001 over 10 min. NEAT2 was originally dissolved in 20 mM Tris-Cl, 10% glycerol, pH
8.0. In the first titration experiment, the buffer was changed to 20 mM each CAPS, MES, and
Tris-Cl (pH 10.4  0.1 at 4 oC). This protein sample was followed by UV-visible spectroscopy at
4 oC every 10 min for the first 2 h and every 30 min for the next 17 h. The pH of this sample
was then adjusted to 6.6  0.1 by 1.0 M HCl and UV-visible spectra were taken every 10 min for
24 h. The pH was then adjusted to 10.5  0.1 by 1.0 M NaOH and UV-visible spectra were
taken every 10 min for 24 h. In the second titration experiment, the buffer was changed to 20
mM each CAPS, MES, and Tris-Cl (pH 6.5  0.1 at 4 oC), and the sample was held at this pH for
2 h till ASoret < 0.001 over 10 min. The sample was then taken to pH 10.1  0.1 and subjected
to UV-visible spectroscopy at 4 oC every 10 min for 24 h.

4.2.2.5 Homology modeling.
A homology model of NEAT2 was built with I-TASSER (Zhang, 2008; Zhang, 2009;
Roy et al., 2010) using homologs including zinc protoporphyrin IsdC (PDB ID 2K78) (Villareal
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et al., 2008), selenomethionine IsdA (PDB ID 2O1A), and holo IsdC (PDB ID 2O6P) (Sharp et
al., 2007) as templates. The same MD simulation on NEAT2 was performed as on NEAT1.

4.2.3 Virtual screening on Shp and SiaA.
4.2.3.1 Ligand preparation.
The ligand database with over 10,000 compounds was downloaded from the publicly
available Maybridge website (http://www.maybridge.com/). The original sdf file for the ligand
library was reprocessed by the LigPrep module (version 2.4, Schrödinger, LLC, New York, NY,
2010) of the Schrödinger suite to generate an unbiased library. LigPrep was run with default
parameters in the force field of OPLS_2005 using Epik at pH 7.0 ±1.0 to generate all
protonation states, isomers, and tautomers of each compound.

4.2.3.2 Protein preparation.
Protein preparation was performed with the Schrödinger Suite 2010 Protein Preparation
Wizard in Maestro. The Shp crystal structure (2Q7A) (Aranda et al., 2007) was pretreated
before the preparation steps were run. The pretreatment steps included deletion of subunit B, as
well as all hemes and glycerols, followed by mutation of both axial methionines (66 and 153) to
alanines. In the Protein Preparation Wizard, bond orders were assigned and the missing
hydrogen atoms added automatically; all water molecules were removed; and the structure was
optimized using exhaustive sampling option and minimized in the force filed of OPLS_2005.
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A homology model of SiaA was built with I-TASSER (Zhang, 2008; Zhang, 2009; Roy et al.,
2010) using the structure of IsdE (Grigg et al., 2007a) as the main template. The SiaA model
was then prepared with Protein Preparation Wizard in the same method as for Shp.

4.2.3.3 Glide screening.
Virtual screening was carried out using Glide v5.6 in which the receptor is held rigid and
the ligand moves freely (Friesner et al., 2004; Halgren et al., 2004; Friesner et al., 2006). A grid
box of 20 × 20 × 20 Å 3 was centered at the heme binding site in the structure; no constraints
were applied. In the case of Shp, the center was half way between the mutated amino acids A66
and A153; in SiaA, the center was half way between amino acids M79 and H229. The prepared
Maybridge ligand library was screened to the protein using a standard precision (SP) glide with
“dock flexibly” and “add Epik state penalties to docking score.” After screening, the top 1000
scoring (most negative docking score) compounds were selected for cross-analysis.

4.2.3.4 Screening analyses.
Screening analyses was accomplished via the modules of IFD (Induced Fit Docking)
(Sherman et al., 2006a; Sherman et al., 2006b) and Prime MM-GBSA (molecular mechanics –
the generalized Born model and solvent accessibility method) calculation (Jacobson et al., 2002;
Jacobson et al., 2004). IFD allows both the ligand and the receptor to move freely during
docking to generate more accurate binding state. This module includes two stages, which are
initial glide docking and prime induce fit. In the initial glide docking step, there is a command of
“trim side chain” which functions in the way that the selected residues are temporarily mutated
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to alanines to provide more space for docking; in the prime induced fit step, the original side
chains are restored. The output results are ranked by the IFD score to estimate of the binding
energy. The more negative the score, the lower the binding energy. In the case of Shp, the top
1000 output compounds from Glide screening and the prepared native apo-Shp were subjected to
IFD with the option of “trim side chains M66 and M153” and the rest parameters in the default
setting.
Prime MM-GBSA, with the MM-GBSA continuum solvation model, is a module to
calculate ligand binding energies. The results were ranked by binding energy. The same top
1000 output compounds from Glide screening and the prepared native apo-Shp were also
subjected to MM-GBSA with atoms within 8 Å of the first processed ligand flexible. The top
100 outputs from IFD and MM-GBSA were compared and the repeated structurally reasonable
compounds were selected for future in vitro experiments. The ligands for SiaA were selected in
the same methods as in Shp.

4.3

Results and discussion.

4.3.1 NEAT1.
4.3.1.1 Expression and purification.
The construct for the first NEAT domain of Shr (NEAT1) included an OmpA signal
peptide followed by a Strep-tag at the N-terminus, followed by the sequence for Shr through the
end of the NEAT1 domain (Ouattara et al., 2010). The OmpA signal peptide led to the
cytoplasmic accumulation of NEAT1 and was cleaved by the leader peptidase of E. coli. The
recombinant NEAT1 was purified from the cell extract by cell disruption followed by FPLC. A
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protein band of the predicted 58 kDa (expected size of the NEAT1 monomer) was observed by
SDS-PAGE.
A positive ion MALDI spectrum gave a peak at 58,900.6 (Figure 4.5). This was
consistent with the cleavage of the OmpA leader peptide just upstream of the Strep-tag (a
molecular weight of 58,944 for the apoprotein starting with the serine before the Strep-tag) and
loss of the heme (which was observed in the spectrum at 616.0). A second preparation showed
the major peak at 29,782, consistent with the doubly charged holoprotein. The ESI mass
spectrum showed a mass of 58,981.5 (Figure 4.6), again consistent with the apoprotein.
NEAT1 is isolated as a ferric protein. In 50 mM Tris-Cl, pH 8.0, 100 mM NaCl, the Soret
band is at 409 nm. In 50 mM sodium phosphate, pH 7.5, the Soret band is at 412 nm (Figure
4.7). NEAT1 is readily reduced by both dithionite and dithiothreitol to give the ferrous form of
the protein with a Soret band at 427 nm as well as Q bands at 530 and 560 nm. The position of
the reduced Soret is the same with both reducing agents (427 nm). However, we note that the
ratio of the Soret bands in the reduced and oxidized forms was 1.7 when reduced with dithionite
(50 mM Tris-Cl, pH 8.0, 100 mM NaCl, done by Darci Block, data not shown) and 1.3 when
reduced with dithiothreitol (50 mM sodium phosphate, pH 7.5). This might be due to differences
in the pH, ionic strength, buffer type or reducing agent and was not pursued.
A weak optical band at approximately 645 nm was also observed for the ferric protein.
In heme binding proteins, the UV-visible absorbance over 600 nm in general is assigned to
charge transfer (CT) band between the heme iron and the ligand (Barker & Freund, 1996; Barker
et al., 1996b; Othman & Desbois, 1998; Perera et al., 2003). The His-Met ligand shows a UVvisible absorbance at 650 nm for S. aureus IsdE (Tiedemann et al., 2008) and 695 nm for horse
heart cytochrome c (Rux & Dawson, 1991; Blouin et al., 2001). A similar ligand set, AcMet (N-
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acetylmethionine)-His from ferric N-acetylmethionine (AcMet) complexes of microperoxidase-8,
shows a UV-visible absorbance in the 690~698 nm range (Othman & Desbois, 1998). The bisMet ligand in ferric bacterioferritin from D. desulfuricans shows a broad band at 715 nm (Romão
et al., 2000). This CT band shift in bis-ligated hemes with at least one methionine ligand leads to
an assumption that bis-ligated hemes with one methionine ligand have a CT band in the 650~700
nm range and that replacement of the second axial ligand histidine to methionine results in an
additional red shift in the CT band depending on various systems. The single tyrosine ligand in S.
aureus Isd NEAT proteins (IsdA, IsdBN2, and IsdHN3) shows a UV-visible absorbance at
625~630 nm (Tiedemann et al., 2008; Pluym et al., 2007). The single methionine ligand in S.
pyogenes Shp mutants M66A and M153A shows a UV-visible absorbance at approximately 610
nm (Ran et al., 2007). There is not enough evidence to determine the NEAT1 coordination state
from the CT band at 645 nm.
Further analysis of NEAT1 was performed using a Sephacryl S-200 column on three
separate batches of purified protein. In each case, three major bands were seen, smaller peaks at
approximately 36 and 40 ml, and a larger peak at 48 ml; data for one of the batches are shown in
Figure 4.8. The SDS-PAGE showed a band of approximately 58 kD (indicating NEAT1
monomer) for each of the fractions. The MALDI mass spectra were essentially the same for
each of the fractions (data not shown). Native PAGE, however, showed a single band only for
Fraction 3. This had a gel position consistent with the dimer of the protein. The elution volume
on Sephacryl S-200 column was also consistent with a dimer by comparing the elution volume
with standard proteins at the same elution condition. Fractions 1 and 2 had substantial
concentrations of multimeric species. Even at very low concentrations (maximum peak
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absorbance at 280 nm of < 0.01), no significant peak eluting later than the dimer was seen,
indicating that this protein is found in dimers or higher multimers even in dilute solution.
UV-visible spectra were recorded for the three fractions (Figure 4.8). Fraction 1 (mixture
of NEAT1 dimer and multimer) showed very little holoprotein; Fractions 2 (mixture of NEAT1
dimer and multimer) and 3 (NEAT1 dimer) were exhibited significantly more heme loading and
were very similar in this regard. Thus, the protein multimerization and heme loading were
related, with the higher multimeric form showing less heme loading. The reason for the
observation that the higher multimeric form shows less heme loading is unclear. In work on the
IsdHN3 NEAT domain, Watanabe et al. found that this domain bound with multiple hemes in
two configurations (Watanabe et al., 2008). They also found that excess heme promoted the
multimerization of the NEAT domains. There are examples of proteins involved in heme
transfer that bind heme at sites other than the primary binding site. For example, ChaN from
Campylobacter jejuni has two cofacial hemes bound between the two monomers of a ChaN
dimer (Chan et al., 2006). The X-ray structure of Shp shows a dimer; each of the two monomers
binds a heme and two additional hemes are found at the interface between the two monomers
(Aranda et al., 2007). Recently two proteins which bind two hemes at the active site have been
characterized. MhuD from Mycobacterium tuberculosis binds two hemes in a stacked geometry
(Chim et al., 2010) as does HmuT from Yersinia pestis (Mattle et al., 2010). Overall, heme can
bind to heme proteins in a variety of ways in a laboratory. Our work and that of Watanabe et al.
indicate that multimerization and heme binding can be associated processes for NEAT domains,
although the details may vary depending on the exact system (Watanabe et al., 2008).
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4.3.1.2 Reconstitution of NEAT1 with Heme.
As isolated after FPLC purification on a Strep-Tactin column, NEAT1 had a Soret/280
nm ratio of less than 1.0. In general, heme proteins have a Soret/280 nm ratio of > 1.0 and this
experimentally observed ratio indicates that the protein is not fully loaded with heme. A series
of efforts were made to reconstitute NEAT1 to make the holoprotein.
In one attempt, hemin (1.6 eq) was added to the protein and the solution incubated for 24
h at 4 °C. The protein was recovered by a centrifugal filter unit and purified by FPLC using a
Sephadex G25 column. Only one peak was seen in the chromatogram (Figure 4.9). The
Soret/280 nm band increased from 0.61 before reconstitution to 1.2 after reconstitution (the
highest ratio seen in our experiments on this protein). The Soret/380 nm ratio was 2.0. The
spectra in the region from 350 to 420 nm before and after reconstitution were identical (Figure
4.10), indicating that the heme added in the reconstitution was in the same binding site as that of
the native protein.
In a second reconstitution, hemin (1.0 eq) was added and the solution was incubated for
30 min at 4 °C. The protein was purified on a Sephadex G25 column. In this instance, three
peaks were observed, all of which had similar UV-visible spectra with a significant shoulder at
350 - 380 nm (Figure 4.11). This shoulder presumably is due to heme that is not bound at the
same binding site as the native protein. The fractions were combined and passed through a
hydrophobic interaction (HIC) FPLC column (Phenyl HP column) (Figure 4.12). This separation
gave an initial sharp peak, which was shown by its UV-visible spectrum to be largely apoprotein
with small amounts of holoprotein (Soret/280 nm ratio of approximately 0.16). This was
followed by fractions spreading out to ~ 30 ml, which had a Soret/280 nm ratio of 1.0 and
Soret/380 nm ratio of 2.1. SDS-PAGE showed that both fractions collected contained NEAT1.
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Native PAGE was not run on these samples. In conjunction with the observation above that
NEAT1 forms dimer and multimer in solution, and that the multimeric state is less heme loaded
than the dimeric state, it may be that the first peak of the column in this experiment is mainly
multimeric, unlike the second broad peak is a mixture of species.
The observation of a substantial 350 – 380 band in the 30 min incubation experiment
(even after G25 chromatography) indicates that heme can bind fairly tightly to the protein at sites
other than the primary binding site. This is consistent with literature observations above. The
observation of this band in the 30 min incubation experiment but not in the 24 h incubation
experiment may indicate that reconstitution is a slow process in this system. Both protocols give
very similar spectra in the end, maximum Soret/280 nm ratios were 1.0 - 1.2. This same ratio
has been seen in previous work (Ouattara et al., 2010). Given a calculated protein absorbance at
280 nm of approximately 38,850 M-1 cm-1 (Gasteiger et al., 2005), and assuming that the heme
contribution to the protein band is minimal and that the protein is fully holo, then the extinction
coefficient for the bound heme would be approximately 40,000 M-1 cm-1. This extinction
coefficient is probably too low for a heme protein, indicating that this protein is difficult to force
to the fully holo state.

4.3.1.3 Denaturation with guanidinium hydrochloride.
NEAT1 can obtain heme from hemoglobin (Ouattara et al., 2010). Presumably it then
transfers the heme to the next binding site in the pathway. In thinking about this transfer process,
it is of interest to determine how easily the protein releases heme. To explore this, we have
performed chemical and thermal denaturation experiments of both the oxidized and reduced
forms of the protein.
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Denaturation with guanidinium hydrochloride is widely used to probe the stability of
heme proteins (Wittung-Stafshede, 1999a; Bowler, 2007). The ferric form of the protein was
treated with GdnCl and the data fit with a standard two state transition model as described in
Materials and Methods (Figure 4.13). The midpoint of the transition occurred at 0.89 ±0.01 M
GdnCl. This midpoint can be compared with other b-type heme proteins (D1/2) including the
hexacoordinated proteins cytochrome b562 (1.5 – 1.8 M) (Wittung-Stafshede et al., 1997;
Wittung-Stafshede et al., 1999); OM cytochrome b5 (2.6 – 3.6 M) (Arnesano et al., 1998;
Silchenko et al., 2000); HasA (2.7 M) (Wolff et al., 2003); MC cytochrome b5 (3.1 M) (Manyusa
et al., 1999); SiaA (3.1 M) (Sook et al., 2008) and the pentacoordinated proteins horse heart
myoglobin (1.6 -1.8 M) (Schechter & Epstein, 1968; Puett, 1973) and sperm whale myoglobin (2
– 2.5 M) (Schechter & Epstein, 1968; Puett, 1973; Hargrove & Olson, 1996). NEAT1 unfolds
the most easily of all of these examples.
Of note also is the steepness of the unfolding transition (m-value of approximately 10).
This high m-value presumably is observed because NEAT1 is found as dimers and multimers in
solution; the m-values generally increase with the number of hydrophobic interactions disrupted
in the denaturation (Myers et al., 1995; Thoren et al., 2006). Because the denaturation is not
entirely reversible, and because the system is dimeric/multimeric, we did not use the D1/2 and mvalues to calculate free energies of unfolding (Pace & Scholtz, 1997).
The unfolding of the ferrous NEAT1 gave a (D1/2) value of 1.12 ±0.01 M. Thus, the
ferrous protein is only slightly more stable to chemical denaturation than the ferric protein. The
difference in the D1/2 values of the two oxidation states varies quite a bit from protein to protein.
For hexacoordinate b-type hemes, cytochrome b562 has a D1/2red - D1/2ox of 4.0 to 4.5 M (WittungStafshede et al., 1997; Wittung-Stafshede et al., 1999) while SiaA has a value of 1.9 M (Sook et
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al., 2008). However, the c-type heme in cytochrome c553 from Desulfovibrio vulgaris has a
D1/2red - D1/2ox of only 0.25 M (Wittung-Stafshede, 1999b). The dimeric/multimeric nature of this
protein means that the process of unfolding involves subunit interfaces as well as the heme active
site. This may be part of the reason that the oxidized and reduced forms of the protein are so
similar.

4.3.1.4 Thermal denaturation.
Thermal denaturation provides another method of assessing the ease of heme loss due
protein unfolding. The thermal denaturation of ferric NEAT1 is shown in Figure 4.14. The
spectra are isosbestic from 20 °C to approximately 50 °C (Soret at 412 nm and a new peak at
~393 nm). After this, the absorbance increases somewhat at the isosbestic point, indicating that
the thermal denaturation is not strictly a two state process. The sample was heated to 60 °C and
then re-cooled to 0 °C. The released heme that does not rebind to the protein may be simply
aggregated, or bond in a non-specific manner to the protein. Spectral analysis indicated only
approximately 76% refolding. Both of these observations indicate that thermal unfolding for this
protein is not a reversible process; therefore, we did not attempt to derive thermodynamic
parameters in this system. To estimate the Tm, we fit the unfolding as a two state process, giving
a value of 47 °C.
The thermal denaturation of the ferrous protein was performed with dithiothreitol as a
reducing agent (Figure 4.14). The spectra were isosbestic in the Q-band region. The Soret
decreased smoothly up to 50 °C. Beyond this, a second, blue-shifted peak appeared at
approximately 400 nm. When re-cooled to 0 °C, the spectrum showed both a band for the
reduced heme at 427 nm and also the new band at 400 nm. The observation that the sample
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refolded (approximately 70%) without additional reducing agent added and the position of the
band in the unfolded protein at 400 nm indicates that the new species is probably not the ferric
protein (Soret at 412 nm) formed by oxidation during the experiment. Fitting the denaturation
as a two state process gave a Tm of approximately 52 °C.
For NEAT1, the Tm values for the ferrous and ferric protein are essentially the same. We
are aware of a few other heme proteins for which thermal denaturation has been measured in
both the ferrous and ferric forms. Four of these are cytochrome c derivatives (His-Met axial
ligands), with Tmred - Tmox of almost 30 °C (Cohen & Pielak, 1995; Lett et al., 1996; Uchiyama et
al., 2004). Cytochrome b562, a b-type heme protein with His-Met ligands, has a Tmred - Tmox
value of 15 °C (Fisher, 1991). For hemopexin, a b-type heme protein with two histidine ligands,
the reduced protein unfolds more easily than the oxidized, but only by about 3 °C (ferric of
64.6 °C and ferrous of 61.4 °C) (Rosell et al., 2005). The similarity of the Tm values of the two
oxidation states is consistent with the similarity of the D1/2 values in the unfolding induced by
guanidinium; the unfolding may be influenced significantly by the dimerization/multimerization
of the protein.
It is common to use a thermodynamic cycle (Figure 4.15) to relate the heme binding
constants in the two oxidation states and the reduction potentials of the heme free in solution and
bound to the protein (Telford et al., 1998; Reedy & Gibney, 2004). This is related to the
unfolding of the protein, in that free heme in solution corresponds to the apoprotein (which is the
same for the oxidized and reduced state). The reduction potential of NEAT1 is approximately
260 mV (Block, 2009), significantly higher than that of free heme which has been estimated to
be about -75 mV (Reddi et al., 2007). This would indicate that the ferrous protein should be
more stable to denaturation than the ferric protein. Experimentally, however, the two oxidation
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states are very similar in their denaturation characteristics. Three factors may help explain this
discrepancy. First, the denaturations are not entirely reversible in either oxidation state, making
a thermodynamic cycle problematic. Second, the proteins samples contain significant apoprotein,
which may also influence the reversibility of the system. Most importantly, the dimerization and
multimerization of the protein may play a significant role. The reduction potential may be fairly
insensitive to the oligomerization state of the protein, while the chemical and thermal
denaturations may be significantly affected by the dissolution of interactions between units of the
dimer/multimer. The difference in conclusions regarding the stability of the ferric and ferrous
states in the denaturation vs. reduction potential approaches may indicate a very large role for
protein-protein interactions in controlling heme transfer in the crowded environment of the cell
wall. It is also noted that the NEAT domains in Shr are only a small fraction (approximately
10% each) of this large protein.

4.3.1.5 Homology modeling.
Hemes can bind to proteins via linkages between the iron center and the atoms from
adjacent amino acid side chains (Schneider et al., 2007). Common axial ligands are His, Met,
Cys and Tyr, with others such as Asn, Gln, Lys, and the N-terminal amine also reported.
NEAT1 does not have Cys in sequence. A homology model of NEAT1 was created via ITASSER with IsdC as the main template. Molecular dynamics was run on this model for 15 ns
(Figure 4.16). In the resulting structure, none of Asn, Gln, His, Lys, and Tyr were close enough
to bind ( 5 Å between the iron and the atom from amino acid). In addition, none of these
residues appeared above or below porphyrin ring during the simulation. In contrast, two
methionines did appear in position to bind on opposite sides of the heme. These two
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methionines appeared to be in relatively unstructured portions of the three dimensional structure.
Liu et al., in their work on MD simulations of heme transport proteins ShuT and PhuT, have
pointed out that flexibility in the structure surrounding the heme may be important in heme
transfer (Liu et al., 2008a).
Methionine 22 was found near the heme iron on the side opposite to that occupied by the
YxxxY motif in IsdA, IsdC and IsdHN3 (Figure 4.17). It was directly adjacent to a serine
toward the N-terminus of the protein, which hydrogen bonds with a heme propionates in
currently known structures of heme binding NEAT domains (Grigg et al., 2010). During the
molecular dynamics, the M22 sulfur to iron distance was between 3 and 12 Å, with a range of 5
to 8 Å for more than half the simulation.
Methionine 107 was found near the heme iron on the side of the heme opposite to M22
(Figure 4.17). The sulfur to iron distance ranged from approximately 5 – 20 Å. During the
second half of the simulation, the predominant structures were those in which both methionines
were within 5 - 8 Å of the heme iron. Overall, M22 spent more time associated with the heme
than did M107. There were a significant number of structures where it seemed that both
methionines were close to the heme, a substantial number where M22 was close and M107
further away, and almost no structures where M107 was close and M22 was further away.
The possibility of M22 and M107 as axial ligands is enhanced by the alignment of the
sequences of the known heme binding NEAT domains: IsdA, IsdBN2, IsdC, IsdHN3, NEAT1
and NEAT2 along with the heme binding protein Shp (Figure 4.3). In this alignment, M22 and
M107 of NEAT1 are at the sequence positions, respectively, of the axial ligands of Shp: M66
and M153 (Aranda et al., 2007).
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The bisMet ligand set is relatively rare in heme proteins. X-ray crystallography has
shown it to be the known axial ligand set in Shp, the protein that is thought to receive heme from
Shr in S. pyogenes (Aranda et al., 2007). Shp in turn transfers heme to SiaA. This latter process
has been studied kinetically in detail (Ran et al., 2007). It has been proposed that the mechanism
involves a transfer of the heme via an intermediate with one axial ligand from each protein.
Such a mechanism has been shown to operate in mercury transfer via cysteine ligands (Brown et
al., 2002; Barkay et al., 2003).
BisMet ligation to heme iron has also been studied in a mutant of cytochrome b562
(H102M) (Barker et al., 1996b). The H102M has bisMet ligation in the reduced state; the Soret
wavelength of reduced H102M is pH dependent. This Soret wavelength reaches maximum when
the pH is increased from approximate 4.0 to 7.5; it then drops when the pH continues increasing
to 9.0. In the high-spin oxidized state of H102M, the spectra indicate that only one of the
methionines is coordinating to the heme; the spectra are independent of pH between values of 4.0
and 9.5. This ability of the bismethionine-heme system to adopt both five-coordinate and sixcoordinate structures is consistent with our observations in the molecular dynamics simulation.
The most widely studied bismethionine protein is bacterioferritin, in which the heme is
bound to two axial methionine residues from different subunits (Cheesman et al., 1990; Harrison
& Arosio, 1996; George et al., 1993; Crichton & Declercq, 2010). This protein again can adopt
various conformations with somewhat different biophysical characteristics. For example, D.
desulfuricans bacterioferritin has both high spin and low spin forms, depending on the buffer
composition (Romão et al., 2000).
NEAT1 has midpoint potentials of 260 ±9 mV (reductive) and 230 ±26 mV (oxidative)
vs. SHE (Block, 2009). Hemes with two axial methionines show a very wide range of reduction
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potentials. The reduction potential of the bis-methionine H102M mutant of cytochrome b562 was
+440 mV at pH 4.8, with reduction coupled to coordination-state changes (Barker et al., 1996b).
The reduction potential for D. desulfuricans bacterioferritin was 140 mV and independent of
whether the protein was in the high-spin (50 mM phosphate buffer) or low-spin (300 mM
phosphate buffer) forms (Romão et al., 2000). The D. desulfuricans protein has iron
uroporphyrin, rather than iron protoporphyrin, as the prosthetic group, though it has been
proposed that the effect of this change on the reduction potential is minor (Romão et al., 2000).
In contrast to the D. desulfuricans protein, the reduction potentials of Azotobacter vinelandii
bacterioferritin were -225 and -475 mV for the apo (no iron, with heme) and iron loaded forms,
respectively (Watt, 1986). Thus, the reduction potential of NEAT1 is consistent with a
bismethionine axial ligand set, although the range of known reduction potentials for the members
of this class is very wide.

4.3.2 NEAT2.
4.3.2.1 Expression and Purification.
NEAT2 was cloned into a plasmid IBA pASK-IBA with an OmpA signal peptide
followed by a Strep-tag at the N-terminus of the construct (Figure 4.18). The recombinant
NEAT2 was purified from the cell extract by cell disruption followed by FPLC on a Strep-Tactin
column. The leader peptide is cleaved from the NEAT2 by cellular proteases. A protein band of
the predicted 21 kDa was observed by SDS-PAGE. The matrix-assisted laser
desorption/ionization (MALDI) mass spectrum showed a peak at 21758.2. The predicted mass

112
for the apoprotein with cleavage between Q and A in the sequence AQAAS is 21706.2,
consistent with the experimental observations.
At low protein loading on an SDS-PAGE gel, NEAT2 was seen as the expected position
(about 21 kDa). However, at high protein loading, an extra band consistent with a dimer was
seen. The high pI of this protein [9.74, predicted by ExPASy (Gasteiger et al., 2005)] made Blue
Native PAGE (Wittig et al., 2006) difficult. The purified NEAT2 was collected and further
analyzed on multimerization by flowing through a Sephacryl S-200 column with sodium
phosphate buffer (50 mM, NaCl 150 mM, pH 7.0) at 0.5 ml/min. However, at very low
concentrations (maximum peak absorbance at 280 nm of < 0.01), only one significant peak was
observed which was consistent with the elution volume of the monomer (about 21 kDa).
The purified protein could be easily oxidized with potassium ferricyanide and reduced
with sodium dithionite. As has been reported previously (Zhu et al., 2008a; Ouattara et al.,
2010), the protein is isolated as a mixture of the oxidized and reduced species. In our hands, the
extent of reduction in the protein as isolated ranged from about 20% to about 80%. The Soret
absorbance of Fe(III) NEAT2 is at 412 nm in buffer (50 mM TrisCl, 100 mM NaCl, pH 8.0); the
Soret absorbance of Fe(II) NEAT2 (reduced by sodium dithionite) is at 429 nm in buffer (Figure
4.19).

4.3.2.2 Guanidinium and thermal unfolding.
To assess the ease of unfolding of NEAT2, the protein was treated with increasing
concentrations of GdnCl. The data were fit with a standard two state transition model (Figure
4.20). The midpoint of the transition occurred at approximately 2.09 ±0.02 M GdnCl for the
ferric protein, and approximately 2.61 ±0.14 M GdnCl for the ferrous protein. We also
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attempted to study the unfolding via thermal denaturation. Heating of the ferric form showed no
change in the Soret at 409 nm from 20 °C to approximately 40 °C. From 40 °C to 55 °C, there
was a very small decrease in the Soret. Beyond this, the absorbance increased throughout the
spectrum, indicting that the protein was aggregating. Very similar behavior was observed for the
ferrous form of the protein.

4.3.2.3 pH Titration – autooxidation and autoreduction.
As has been reported previously, Shr (Zhu et al., 2008a; Ouattara et al., 2010) and the
NEAT2 domain (Ouattara et al., 2010) are isolated as a mixture of oxidized and reduced protein.
In our hands, the extent of reduction of NEAT2 as isolated ranged from 20% to 80%. The
protein was isolated as a mixture of oxidation states even in the presence of 1% EDTA in the
running buffer of the Strep-Tactin column. This argues that adventitious metal ions in solution
are not serving as the primary source of electrons for the autoreduction. No effort was made to
exclude oxygen in the chromatography, indicating that autoreduction occurs smoothly in air.
Block and Rodgers observed apparent spontaneous autoreduction and autooxidtion as a function
of pH (Block, 2009). Experiments were performed in our laboratory to characterize this process
in detail.
The first titration was a titration from high pH to low pH (Figure 4.21). As initially
prepared in 20 mM each CAPS, MES, and Tris-Cl at pH 10.4  0.1, NEAT2 was initially
approximately 65% in the reduced form. Over 17 h at 4 oC, the reduced Soret increased by <
0.04 and the oxidized Soret decreased by < 0.01 absorbance units. The ratio of the
reduced/oxidized form remained almost unchanged. After the pH was adjusted to 6.6  0.1, the
reduced Soret disappeared, and the oxidized Soret increased and red shifted by 2 nm over 24 h.
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The protein converted completely to the oxidized form. This change did not have an isosbestic
point. When the pH of this sample was increased to 10.5  0.1, approximately 30% of the
protein converted to the reduced form over 24 h.
In a second experiment, a NEAT2 solution was prepared at pH 6.5  0.1 (data not shown).
The solution, initially a mixture of the oxidized and reduced protein, fully oxidized over 2 h at 4
C. After the pH was increased to 10.1  0.1, approximately 10% of NEAT2 converted to the
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reduced form over 24 h.
These pH titration experiments indicate that NEAT2 fully autooxidizes easily in air at
acidic pH, that NEAT2 remains the reduced form at basic pH over 24 h at 4 oC, and that once
NEAT2 is oxidized, only part of the protein (10 ~ 30%) will undergo autoreduction at basic pH.
Autoreduction of other heme proteins has been reported. Some of the most studied
proteins (O'Keeffe & Anthony, 1980a) are the cytochromes cH and cL from Methylobacterium
extorquens (originally called Pseudomonas AM1 or Methylobacterium AM1 (Nunn & Anthony,
1988)). Cytochrome cL acts as an electron acceptor for methanol dehydrogenase, and transfer
electrons to cytochrome cH (Anthony, 1992). Cytochrome cH then donates electrons to oxidase.
Cytochrome cL is a protein of 21 kDa with a low isoelectric point (pI) of 4.2 and a reduction
potential of +256 mV (O'Keeffe & Anthony, 1980b). It has a six-coordinated cysteinecovalently-bonded heme c with a histidine as the fifth ligand (Williams et al., 2006). The sixth
ligand is Met109 in solution (Afolabi et al., 2001) and His112 in the crystal (Williams et al.,
2006), indicating the relatively flexible nature of the heme binding site. Cytochrome cH is a
protein of 11 kDa with a high pI of 8.8 and a reduction potential of +294 mV (O'Keeffe &
Anthony, 1980b). The heme at the binding site is covalently bonded to a cysteine and sixcoordinate with Met and His (Read et al., 1999). For these cytochromes, the autoreduction is
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first-order in 30% glycerol, with a rate constant that increases by approximately a factor of 5 as
the pH of the solution is raised from 9 to 11 (O'Keeffe & Anthony, 1980a).
In other studies, cytochrome c-552 in Gram-negative bacterium Pseudomonas alcaliphila
AL15-21T is isolated in an almost fully reduced state when grown at pH 10 (Matsuno et al.,
2007). This reoxidized cytochrome by potassium ferricyanide with no glycerol autoreduces at
basic pH, but not at neutral pH. The redox potential of the heme in this protein is also sensitive
to pH, increasing from +228 mV to +276 mV (Em values) as the pH is raised from 7.0 to 8.3.
Cytochrome c6 from Monoraphidium braunii, with a pI of 3.6, is also purified predominately in
the reduced state and autoreduces after being oxidized with ferricyanide, especially above pH 8
(Campos et al., 1993). The reduction potential of this cytochrome is about 358 mV at pH 5.5 –
7.0, and pH dependent between pH 7 and 9 (decreasing to about 300 mV at pH 9). Cytochrome
ƒ also undergoes autoreduction. The Japanese radish protein, with a midpoint potential of +350
mV, autoreduces slowly (Tanaka et al., 1978) and the spinach protein reduces spontaneously too
(Garewal & Wassermann, 1972). Overall, the higher the reduction potential of the heme, the
more likely it is to reduce, as expected. Although most reports of autoreduction have not
involved formal studies of the process, it does seem that NEAT2, with a reduction potential of
+260 mV, is at the low end of the proteins that autoreduce easily.
The source of reducing equivalents in the NEAT2 autoreduction process is not clear.
Adventitious metal ions are known to contribute to the autoreduction of cytochrome c (Volkov et
al., 2005). The observation that the protein is isolated as a mixture of oxidized and reduced
protein even in the presence of EDTA argues that metal ions are not the primary source of
electrons in this instance. Neutral tyrosine radicals might be able to contribute to autoreduction
of yeast cytochrome c (Moench & Satterlee, 1995).
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NEAT2 has 19 lysines and a pI of 9.74. It is possible that deprotonation of a lysine near
the heme allows autoreduction to take place. Such a mechanism was proposed early on for the
cytochrome cL system (Davidson, 1993) in which it was hypothesized that increasing the pH
resulted in deprotonation of a nearby group, which was then able to transfer an electron to the
iron center. In model systems, amines readily reduce iron porphyrins in solution (Epstein et al.,
1967; Radonovich et al., 1972; Straub & Connor, 1973; Del Gaudio & La Mar, 1976; Del
Gaudio & La Mar, 1978; Connor & Straub, 1979; Srivatsa & Sawyer, 1985; Castro et al., 1986;
Shin et al., 1987; Balch et al., 1996; Zhong et al., 1996).

4.3.2.4 Homology modeling.
A homology model of NEAT2 was built with I-TASSER (Zhang, 2008; Zhang, 2009;
Roy et al., 2010) using the structure of zinc protoporphyrin IsdC (Villareal et al., 2008) as the
main template. The homology model indicated that the heme was in an exposed position on the
surface of the protein. No histidine was near the putative binding site and the N-terminal amino
group was located on the opposite surface of the protein. Heme binding NEAT proteins
characterized to date with X-ray or NMR data have a tyrosine axial ligand in a YxxxY motif.
Sequence alignment of NEAT2 with these structures [IsdA (Grigg et al., 2007b), IsdC (Sharp et
al., 2007), IsdHN3 (Watanabe et al., 2008)] shows that NEAT2 does not have tyrosines in either
of these two analogous positions. In line with this, no tyrosine in the simulation was closer than
10 Å.
Residues that are known to serve as heme binding ligands and that were in the general
vicinity of the heme binding pocket during molecular dynamics simulation included Met26,
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Lys29, Lys54, Met58, Met 136, and Gln146 ( 5 Å between the iron and the possible binding
atom from the amino acid) (Figure 4.22).
Met26 and Lys29 were found on the side opposite to the YxxxY heme binding motif in
IsdA, IsdC and IsdHN3. Met26 was the closest ligand during the entire simulation. This had a
sulfur to iron distance of 3 to 12 Å, with a range of 3 to 7 Å for more than 75% of the simulation.
Lys29 came close to the iron during the simulation. Although this was > 15 Å from the heme for
the majority of the simulation, it did come as close as 4 to 7 Å.
Overall, the molecular dynamics simulation indicated that Met26 was a likely axial
ligand. A sequence alignment of NEAT2 with the known heme binding NEAT domains [IsdA
(Grigg et al., 2007b), IsdBN2, IsdC (Sharp et al., 2007), IsdHN3 (Watanabe et al., 2008)], and
NEAT1 (Zhu et al., 2008a) along with the heme binding protein Shp (Aranda et al., 2007),
showed that Met26 was in the same position as M22 in NEAT1 and M66 in Shp. M66 in Shp is
known from X-ray data to be one of the two axial ligands in this protein; the other is M153
(Aranda et al., 2007). M22 is also hypothesized above to be an axial ligand in NEAT1. The
homologous methionines in NEAT1, NEAT2 and Shp are all directly adjacent to a serine toward
the N-terminus of the protein; this serine hydrogen bonds with a heme propionate in currently
known structures of heme binding NEAT domains (Grigg et al., 2010).
On the side same to the YxxxY heme binding motif in IsdA, IsdC and IsdHN3, the
possible axial ligands include Lys54, Met58, Met 136, and Gln146 ( 5 Å between the iron and
the possible binding atom from the amino acid for some of the simulation). Lys54 and Met58
ranged from 4 to 15 Å, with approximately half of the structures showing distances of < 10 Å for
both of these residues. Met136 was generally quite far from the heme (> 12 Å) but there was a
small set of structures with the sulfur within 4 to 8 Å of the iron. Gln146 started near the heme
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at the beginning of the simulation, but moved to a substantial distance (> 15 Å) after about 2 ns,
and did not return during the simulation. When Lys29 and Lys54 in NEAT2 are near the heme
ring, they are located close to the vinyl side chains. Overall, it appeared that the best candidates
for a possible second axial ligand were Lys54, Met58, and Met 136. None of these have
sequence homology to known heme binding NEAT domains. Both the Met/Lys and Met/Met
motifs are relatively rare in heme binding proteins. Examples with a Met/Lys axial ligand set
include ethylbenzene dehydrogenase from Aromatoleum aromaticum (Kloer et al., 2006) and
dimethylsulfide dehydrogenase (McDevitt et al., 2002; Kloer et al., 2006; Creevey et al., 2008).

4.3.3 Virtual screening on Shp and SiaA.

To locate the potential candidates for inhibition of the heme transfer pathway in S.
pyogenes, virtual screening was run on S. pyogenes Shp and SiaA. Shp is used because it is the
only protein along the heme transport with an available X-ray structure at this moment; SiaA is
used because it has a reliable homology model built upon S. aureus IsdE (sequence identity of
45%). After virtual screening on both proteins, compounds having the lowest MM-GBSA
binding energy and lowest IFD score were selected. For Shp, 19 compounds were chosen (Table
4.6). The binding energy of these compounds to subunit B of Shp was -67 ~ -48 kcal/mol and
the IFD score of these compounds to subunit B of Shp was -297 ~ -295. Two of these
compounds are insoluble with clogP values larger than 5.0. The remaining 17 molecules shared
similarities of more than three nitrogen atoms and at least one heteroaromatic ring; all these
molecules were flexible to some extent. For SiaA, 12 compounds were selected (Table 4.7).
Compared to Shp, the binding energy was higher by about 10 kcal/mol and the IFD score was
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about 200 more negative. Two of these compounds (ligand_8632 and 8644) had a clogP value
larger than 5. The set of molecules in general contained several aromatic rings connected by one
to four atoms bridges. We note that ligand_8061 is an analog to benzamidine which is a
reversible inhibitor of trypsin, trypsin-like enzymes, and serine proteases; this similarity may
reduce its potential as a drug candidate.
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Postscript.
Yu Cao was responsible for thermal unfolding experiments, partial NEAT1 purification,
reduced NEAT2 GdnCl unfolding, pH titration, homology modeling, MD simulation, and virtual
screening. Heme reconstitution and GdnCl unfolding of NEAT1, and oxidized NEAT2
unfolding were performed by You Zhuo. NEAT2 was prepared by Giselle Delgado. The
construction was afforded by Dr. Zehava Eichenbaum’s laboratory. Resonance Raman
spectroscopy was done by Dr. Darci Block in Dr. Kenton Rodgers’ laboratory, as were
electrochemistry experiments (North Dakota State University, not discussed in this dissertation).
I also wish to give credit to Dr. Siming Wang for fruitful discussions on mass spectral analyses.
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Figure 4.1 ClustalW2 sequence alignment of YfeX and EfeB in E. coli K12.
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Figure 4.2 Sequence alignment of ShrNEAT with S. aureus Isd proteins, B. anthracis NEAT
domains, and S. pyogenes Shp.
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Figure 4.3 Sequence alignment of ShrNEAT with S. aureus Isd proteins and S. pyogenes Shp.
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mkktaiaiavalagfatvaqaaswshpqfeksggggglvprgsrdrgpef|ksqeplvqsqlvttvaltqdnrllveeigpyasqsagke
yykhiekiivdndvyekslegertfdinyqgikinadlikdgkheltivnkkdgdilitfikkgdkvtfisaqklgttdhqdslkkdvlsdk
tvpqnqgtqkvvksgkntanlslitklsqedgailfpeidrysdnkqikaltqqitkvtvngtvykdlisdsvkdtngwvsnmtglhlgt
kafkdgentivisskgfedvtitvtkkdgqihfvsakqkqhvtaedrqstkldvttlekaikeadaiiakesnkdavkdlaeklqvikdsy
keikdsklladthrllkdtiesyqagevsinnltegtytlnfkankenseessmlqgafdkraklvvkadgtmeismlntalgqflidfsie
skgtypaavrkqvgqkdingsyirseftmpiddldklhkgavlvsamggqesdlnhydkytkldmtfsktvtkgwsgyqvetddke
kgvg|levdlqgdhgl*
Figure 4.4 Shr-NEAT1 construct. The OmpA leader is in yellow. The Strep-Tag sequence in
fuchsia is WSHPQFEK. The commercial plasmid also has a thrombin consensus sequence
LVPRGS (light blue, not used for cleavage in these experiments). The two DUF (domain of
unknown function) sequences are shown in khaki. The NEAT sequence is shown in green. The
sequence is designated as NP_269809.1 (SPy_1798) (Ferretti et al., 2001). The initial vertical
red line indicates the beginning of the cloned wild-type sequence (minus the original N-terminal
sequence of MKKISKCAFVAISALVLIQATQTV). The second vertical red line indicates the
end of the cloned wild-type sequence.
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Figure 4.5 The positive-ion mode MALDI mass spectrum [(+)MALDI-MS] of NEAT1 after
purification through a Strep-Tactin column. The calculated molecular weight is 58944 for
apoNEAT1. The sample was analyzed using an MDS SCIEX 4800 MALDI TOF/TOF Analyzer
in positive ion mode. The matrix was prepared with 10 mg/ml sinipinic acid, 30% acetonitrile
and 0.1% trifluoroacetic acid.
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Figure 4.6 (+)ESI-MS spectrum of NEAT1 after purification through the Strep-Tactin column.
The peak at 58981.5 corresponds to the apoprotein at 58944.41. The spectrum was recorded
using a Micromass Q-TOF Micro mass spectrometer in positive mode. Samples were prepared
in a solution containing 50:50 acetonitrile/water and 0.1% formic acid.
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Figure 4.7 Normalized UV-visible absorbance spectra of Fe(III) NEAT1 (black) and Fe(II)
NEAT1 (red, reduced by dithiothreitol) in 50 mM sodium phosphate, pH 7.5.
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Figure 4.8 Size exclusion chromatography (SEC) for NEAT1. (A) The SEC elution trace
monitored at 280 nm. The fractions were collected by flowing through a Sephacryl S-200
column with the buffer (sodium phosphate 50 mM, NaCl 150 mM, pH 7.0) at 0.5 ml/min. Three
major fractions were observed and collected as F1, F2 and F3; (B) UV/visible spectra of the
three fractions are colored with blue, red and black for F1, F2 and F3, respectively. Also the
protein before SEC is shown in green. The spectra are normalized at protein absorbance; (C)
SDS-PAGE of the fractions and NEAT before SEC; (D) Native-PAGE of the fractions and
NEAT1 before SEC.
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Figure 4.9 Chromatogram of the Sephadex G25 purification on 1.6 eq heme reconstituted
NEAT1. The column was eluted with phosphate buffer (100 mM, pH 8.5) at 1.0 ml/min,
monitored at 405 nm.
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Figure 4.10 UV/visible spectra of NEAT1 in phosphate buffer (100 mM, pH 8.5) before and
after reconstitution with approximately 1.6 eq heme.
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Figure 4.11 (A) Chromatogram of the FPLC purification (Sephadex G25 column) on NEAT1
after reconstitution with approximately 1.0 eq heme. The column was eluted with 100 mM, pH
8.0 Tris-Cl buffer at 5.0 ml/min, monitored at 405 nm; (B) UV/visible spectra of the three
NEAT1 fractions in 100 mM Tris-Cl, pH 8.0.
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Figure 4.12 Separation of NEAT1 reconstitution product on hydrophobic interaction column
(HIC, Phenyl HP column, GE, 5 ml). The column was eluted at 1.0 ml/min, first with 13 ml
buffer A (20 mM MES, 1.5 M NaCl, pH 5.0), and second with linear gradient of 100% buffer A
to 100% buffer B (20 mM, pH 5.0, MES) over 50 ml elution volume. (A) The HIC elution trace
monitored at 405 nm. Two fractions were observed and collected as F1 and F2; (B) UV/visible
spectra of the two fractions are colored with red and black for F1 and F2 respectively.
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Figure 4.13 The fraction of unfolded NEAT1 as a function of [GdnCl] for oxidized (observed at
411 nm, in black) and reduced states (427 nm, in red).
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Figure 4.14 Thermal denaturation of NEAT1 in sodium phosphate buffer (50 mM, pH 7.5)
monitored by UV-visible spectrometer. (A) The fraction of folded NEAT1 as a function of
[GdnCl]; (B) The spectrum of Fe(III) NEAT1 (20 oC to 60 oC); (C) The spectrum of Fe(II)
NEAT1 (0 oC to 60 oC).
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Figure 4.15 The thermodynamic cycle of hemoproteins.
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Figure 4.16 The distance in NEAT1 between the side chains of amino acids and the iron center
of heme over time. Dynamic simulations of NEAT1 used an explicit TIP3P (Jorgensen et al.,
1983) water cubic box in the Amber 8 program (Case et al., 2005). The all-atom parm99SB
force field parameters (Hornak et al., 2006) and the heme all-atom force field parameters
(Giammona, 1984) were used. During the simulation, a 50 ps minimization step with an
integration time step of 0.001 ps followed by two steps with an integration time step of 0.002 ps
at 300 K (a 50 ps MD step and a 50 ps equilibration step) were used to minimize and equilibrate
the system in a NTP ensemble to a pressure of 1 bar (1 bar = 100 kPa) and a temperature of 300
K. Then a 15 ns dynamic simulation step at 300 K with an integration time step of 0.002 ps was
applied.
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Figure 4.17 Heme binding by IsdA, IsdC, Shp, and Shr NEAT1. (A) The IsdA (PDB ID: 2ITF)
binding pocket; (B) the IsdC (PDB ID: 2O6P) binding pocket; (C) the Shp (PDB ID: 2Q7A)
binding pocket; (D) the Shr NEAT1 binding pocket (a snap shot of the homology model during
molecular dynamics).
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MKKTAIAIAVALAGFATVAQAASWSHPQFEKSGGGGGLVPRGSRDRGPEFLNQKQ
LRDGIYYLNASMLKTDLASESMSNKAINHRVTLVVKKGVSYLEVEFRGIKVGKML
GYLGELNYFVDGYQRDLAGKPVGRTKKAEVVSYFTDVTGLPLADRYGKNYPKVL
RMKLIEQAKKDGLVPLQVFVPIMDAISKGSGLQTVFMRLDWASLTTEKAKVV
OmpA leader – Strep-tag – linker – thrombin cleavage site – N2

Figure 4.18 Shr-NEAT2 construct. This sequence is composed of the OmpA leader (outer
membrane protein A, red), a Strep-tag sequence used for purification (green), a linker (black),
and a potential thrombin cleavage site (blue, thrombin cleavage would occur between arginine
and glycine), and the sequence of NEAT2.
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Figure 4.19 UV-visible spectra of oxidized (black) and reduced (red) NEAT2 in 50 mM TrisCl,
100 mM NaCl, pH 8.0. [Data taken by Dr. Darci Block in Dr. Kenton Rodgers’ laboratory.]
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Figure 4.20 Guandinium-induced unfolding of Fe(II) and Fe(III) NEAT2. Fe(III) NEAT2 in
black and Fe(II) NEAT2 in red.
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Figure 4.21 pH titration of NEAT2 in 20 mM each CAPS, MES, and Tris-Cl at 4 oC monitored
by UV-visible spectrometer. (A) After equilibration in each step. (B) Equilibration in step 2 at 1
h interval.
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Figure 4.22 The distance in NEAT2 between the side chains of amino acids and the iron center
of heme over time. Dynamic simulations of NEAT2 used an explicit TIP3P (Jorgensen et al.,
1983) water cubic box in the Amber 8 program (Case et al., 2005). The all-atom parm99SB
force field parameters (Hornak et al., 2006) and the heme all-atom force field parameters
(Giammona, 1984) were used. During the simulation, a 50 ps minimization step with an
integration time step of 0.001 ps followed by two steps with an integration time step of 0.002 ps
at 300 K (a 50 ps MD step and a 50 ps equilibration step) were used to minimize and equilibrate
the system in a NTP ensemble to a pressure of 1 bar (1 bar = 100 kPa) and a temperature of 300
K. Then a 15 ns dynamic simulation step at 300 K with an integration time step of 0.002 ps was
applied.
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Table 4.1 Summary of Isd system in S. aureus.
Protein

PDB ID

Oxi-state

Holo/apo

2ITE

/

Apo

2ITF

Fe(III)

Holo

IsdC

2O6P

Fe(III)

Holo

(Sharp et al., 2007)

IsdH1

2H3K

/

Apo

(Pilpa et al., 2006)

2E7D

/

Apo

2Z6F

Fe(III)

Holo

IsdE

2Q8Q

Fe(III)

Holo

(Grigg et al., 2007a)

IsdG

1XBW

/

Apo

(Wu et al., 2005)

IsdG-N7A

2ZDO

Fe(III)

Holo

(Lee et al., 2008)

IsdI

3LGM
3LGN

Fe(II)
Fe(III)

Holo
Holo

(Reniere et al., 2010)

IsdA

IsdH3

Reference
(Grigg et al., 2007b)

(Watanabe et al., 2008)
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Table 4.2 EPR summary on heme proteins with bis-Met or single Met ligand, and bis-thioether porphyrin.
Axial
Ligand

PDB
ID

Heme

Protein

Organism

g values

Notes

Reference

1QQ3
(wildtype)

b

Fe(III)
R98C/H102M

E. coli

3.19, 2.25

pH 4.8, low-spin, artifact of
freezing at g = 5.9

(Barker et al.,
1996b)

3IS7

b

2.86, 2.32, 1.40

/

1SOF

b

2.88, 2.31, 1.46

/

2HTN

b

2.88, 2.31, 1.48

/

3GVY

b

2.87, 2.32, 1.48

/

3IS7

b

bacterioferritin

2.86, 2.32, 1.48

1SOF

b

bacterioferritin

(Cheesman et al.,
Low-spin
1992)
A whole EPR and MCD paper

Met Met
Met 7
Met102
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52

1SOF

b

Fe(III)
bacterioferritin
Fe(III) Fe(III)
bacterioferritin
Fe(III)
bacterioferritin
Fe(III)
bacterioferritin

Fe(III)
bacterioferritin

Pseudomonas
aeruginosa
Azotobacter
vinelandii
E. coli
Rhodobacter
sphaeroides
Pseudomonas
aeruginosa
Azotobacter
vinelandii
Azotobacter
vinelandii

Wild-type Shp
Met66
Met153

2Q7A

b

M66A
M153A

2.88, 2.31, 1.46

4.3, 2.89, 2.34, 1.46

(Cheesman et al.,
1990)

4.30 – monomeric nonheme
Fe(III),
2.89~1.46 – low-spin heme
Different concentrations of
protein were done.

(Watt et al., 1993)

EPR figure in paper

(Ran et al., 2007)

/
Streptococcus
pyogenes

/
/
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Axial
Ligand

PDB
ID

Heme

2J7A

b

Protein

Organism

g values

Notes

Reference

Desulfovibrio
vulgaris

/

No EPR data

(Rodrigues et al.,
2006)

E. coli

/

pH 7.1, high-spin, EPR figure
in paper

(Barker et al.,
1996b)

E. coli

/

pH 9.2, high-spin, EPR figure
in paper

(Barker et al.,
1996b)

In solution of
CH2Cl2-CHCl3

2.90, 2.37, 1.48

pentamethylene sulfide (PMS)

(Mashiko et al.,
1981)

CH2Cl2

2.89, 2.37, 1.46

Low-spin,
Tetrahydrothiophene (THT),
Porphyrin-imidazole complex
also reported here

(McKnight et al.,
1991)

Met alone

Met49

Met

Met

1QQ3
(wildtype)
1QQ3
(wildtype)

b

b

cytochrome c
quinol
dehydrogenase
Cytochrome
b562 mutant,
Fe(III)H102M
Fe(III)
R98C/H102M

Model compound, Bis-thioether Fe(III) porphyrin
/

/

/

/

/

/

/

/

/

PorphyrinPMS complex
TetraphenylporphyrinTHT complex
OctaethylporphyrinTHT complex

CH2Cl2

2.94, 2.30, 1.43
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Table 4.3 EPR calculation on bis-Met heme proteins and bis-thioether porphyrins.
Axial
Ligand

Protein

Organism

gx

gy

gz

/λ

V/

Reference

pH 4.8, Fe(III)
R98C/H102M

E. coli

0.87 (cal.)

2.25

3.19

1.91

0.59

(Barker et al.,
1996b)

-2.32

2.86

-1.40

2.45

0.62

-2.31

2.88

-1.46

2.72

0.65

-2.31

2.88

-1.48

2.79

0.65

-2.32

2.87

-1.48

2.72

0.64

-2.32

2.88

-1.48

2.71

0.64

-2.31

2.88

-1.46

2.72

0.65

-2.34

2.89

-1.46

2.61

0.63

(Watt et al., 1993)

In solution of
CH2Cl2-CHCl3

-2.37

2.90

-1.48

2.56

0.62

(Mashiko et al.,
1981)

CH2Cl2

-2.37

2.89

-1.46

2.49

0.61

CH2Cl2

1.43

2.30

2.94

2.75

0.65

Met Met
Met 7
Met102
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52

Fe(III) Fe(III)
bacterioferritin

Pseudomonas
aeruginosa
Azotobacter
vinelandii

Fe(III) bacterioferritin

E. coli

Fe(III) bacterioferritin

Fe(III) bacterioferritin
bacterioferritin
bacterioferritin
Fe(III) bacterioferritin

Rhodobacter
sphaeroides
Pseudomonas
aeruginosa
Azotobacter
vinelandii
Azotobacter
vinelandii

(Cheesman et al.,
1990)

(Cheesman et al.,
1992)

Model compound, Bis-thioether Fe(III) porphyrin
Bisthioether
Bisthioether
Bisthioether

Porphyrin-PMS
complex
Tetraphenyl-porphyrinTHT complex
Octaethyl-porphyrinTHT complex

(McKnight et al.,
1991)
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Table 4.4 MCD summary on heme proteins with bis-Met or single Met ligand, and bis-thioether porphyrin.
Axial
Ligand

PDB
ID

Heme Protein

Organism

Wavelength
(nm)

Notes

Reference

E. coli

at pH 4.8 rt,
2150, 1600,

2150 for bis-Met;
1600 a vibrational sideband
(McKnight et al., 1991);

(Barker et al., 1996b)

2240 for bis-Met,
No figure in paper

(Cheesman et al.,
1990)

Figure in paper,
A whole EPR and MCD paper

(Cheesman et al.,
1992)

No CD data here

(Ran et al., 2007)

Met-Met
Met7
Met102
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met52
Met66
Met153

1QQ3
(wildtype)

b

3IS7

b

1SOF

b

2HTN

b

3IS7

b

1SOF

b

2Q7A

b

Fe(III)
R98C/H102M
Fe(III)
bacterioferritin
Fe(III)
bacterioferritin
Fe(III)
bacterioferritin
Fe(III)
bacterioferritin
Fe(III)
bacterioferritin
Shp

Pseudomonas
aeruginosa
Azotobacter
vinelandii
E. coli
Pseudomonas
aeruginosa
Azotobacter
vinelandii
Streptococcus
pyogenes

Max 2240
Max 2270
Max 2270
710, 2240
710, 2270
/
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Axial
Ligand

PDB
ID

Heme Protein

Organism

Wavelength
(nm)

Notes

Reference

Desulfovibrio
vulgaris

/

No CD data here

(Rodrigues et al.,
2006)

at pH 7.0,
610, 842

604~610nm indicating highspin charge-transfer (CT);
810~842 nm, dispersion-shaped
center, porphyrin → Fe(III) CT

(Barker et al., 1996b)

Tetrahydrothiophene (THT)
Porphyrin-imidazole complex
also reported here

(McKnight et al.,
1991)

Met alone

Met49

2J7A

Met

1QQ3
(wildtype)

b

b

cytochrome c
quinol
dehydrogenase
Cytochrome
b562 mutant
Fe(III)H102M
Fe(III)
R98C/H102M

E. coli

at pH 9.2,
604, 810

Model compound, Bis-thioether Fe(III) porphyrin

/

/

/

/

/

/

Tetraphenylporphyrin-THT
complex

CH2Cl2-Et2O

Octaethylporphyrin-THT
complex

CH2Cl2-Et2O

~660, ~1900,
~2310
(these read
from figures)
690, 1600,
2130
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Table 4.5 Redox potential summary on heme protein with bis-Met or single Met ligand.
Axial
Ligand

PDB
ID

Heme

Protein

b

Cytochrome b562
mutant,
R98C/H102M,
Fe(III) or Fe(II)
H102M, Fe(II)
protein,

Organism

Redox potential (mV)

Notes

Reference

Met Met

Met 7
Met102

Met52
Met52

1QQ3
(wildtype)

1SOF

b

+440 ±5 (vs SHE) at pH 4.8
E. coli
+420, +300, +240 mV at pH
5.3, 6.2, 7.0

Bacterioferritin
Azotobacter
(cytochrome b557.5) vinelandii

-446 mV for heme reduction,
-416 mV for the bulk iron at
pH 7.0

pKa titrations;
pH denpendence of
the midpoint potential
of R98C/H102M
(reversible below pH
6.5)
Hard copy from
library to check
Reduction potential
for heme b is more
negative than the core
iron

(Barker et
al., 1996b;
Barker et al.,
1996a)

(Stiefel &
Watt, 1979)

-475 mV for heme reduction;

Met52
Met52

1SOF

b

bacterioferritin

Azotobacter
vinelandii

-420 ±20 mV for core iron
reduction at pH 7~9, -390
mV at pH 6;
-225 mV at pH 8.0 for
apobacterioferritin
(containing only heme)

(Watt, 1986)

150
Axial
Ligand

PDB
ID

Heme

Protein

Organism

Redox potential (mV)

Notes

Reference

(Watt et al.,
1993)

(Huang et al.,
1998)

Met Met

Met52
Met52

1SOF

b

bacterioferritin

Azotobacter
vinelandii

/

two-step reduction
process consisting of a
pH independent
reduction of heme in
holo AVBF followed
by a pH dependent
reduction of the
mineral core.

-125, -310, -370 mV for the
reduction potentials of
electron tunnels towards iron
release

No heme protein
redox potential data

+140 ±10 mV (vs SHE) at
pH 7.6

(Romão et
al., 2000)

Very low

(Meyer &
Cusanovich,
1985)

Met52
Met52

1SOF

b

bacterioferritin

Azotobacter
vinelandii

Met57
Met57

1NF4
[red]
1NF6
[oxi]

Probably
Fe
uroporph
yrin

bacterioferritin

Desulfovibrio
desulfuricans

bacterioferritin

Rhodobacter
sphaeroides

Met52
Met52

3GVY

b

Met alone

Met49

2J7A

b

cytochrome c
quinol
dehydrogenase

Desulfovibrio
vulgaris

No data

Suggested in the paper
that Met ligand
contributing to a
higher reduction
potential

(Rodrigues et
al., 2006)
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Table 4.6 Potential ligands for Shp after virtual screening.

ligand_12515
ligand_14896
ligand_18190
ligand_15885(15887)
ligand_17071
ligand_10566
ligand_11451
ligand_597
ligand_4442
ligand_12468
ligand_14960
ligand_19410
ligand_2016
ligand_3448
ligand_3598
ligand_2015
ligand_6651
ligand_14990
ligand_9137

Catalog No.
HTS13112
JFD02062
RH02021
JFD02942
SPB04479
SEW02506
BTBS00006
AW00789
S04811
PD00703
RF00275
SPB08159
BTB01565
BTB03609
HTS02812
BTB01564
HTS06424
RF00291
SCR01207

MM-GBSA G
-67.11
-65.85
-65.00
-64.45
-63.76
-62.04
-60.03
-59.31
-59.25
-57.47
-54.11
-53.40
-51.99
-51.20
-50.56
-49.55
-49.27
-48.83
-47.82

IFD Score
-296.85
-298.71
-295.76
-304.58
-301.87
-299.65
-297.48
-297.11
-295.45
-295.61
-295.17
-296.57
-296.14
-296.73
-297.03
-295.82
-296.16
-299.16
-295.48

MW (g/mol)
331.40
593.76
263.34
602.65
432.37
491.42
651.76
253.65
460.58
303.79
531.53
317.38
347.87
383.90
369.46
317.39
248.32
631.54
342.49

c_log_p
2.95
1.23
3.11
0.95
5.55
3.09
6.10
2.32
2.15
-0.71
6.10
2.51
3.70
5.40
2.40
2.67
1.28
6.10
1.43
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HCl
HCl
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S
N S
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S

S

N

N
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N

N
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N

N
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NH3

Cl
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OH N

H
N

F

S

N

N
S
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N

CF3

O

F

CF3

CONH2
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OH
Cl
S
Cl

N

N

O

N

O

ligand_17071
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O

F

O

F

O

H
N

N
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N
S

Cl
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O
O
O

r

O

N
H

N
O
H HN
O
s

O
S
O

Cl
HN
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H
N
S S
O O
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HN

F

S

S
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NH2

O
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O N
S
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H
N

N
H
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Table 4.7 Potential ligands for SiaA after virtual screening.

ligand_8632
ligand_8335
ligand_8644
ligand_7675
ligand_6774
ligand_317
ligand_8061
ligand_6310
ligand_6223
ligand_900
ligand_4259
ligand_559

Catalog No.
SPB07243
SPB06820
SPB07259
RH01652
BTB08467
SEW02341
DP01770
CD10587
CD10370
GK03640
CD05371
HTS11186

MM-GBSA G
-49.70
-43.93
-43.50
-42.27
-41.87
-40.34
-40.09
-39.73
-39.66
-38.82
-38.77
-38.61

IFD Score
-531.43
-529.62
-534.55
-531.98
-530.00
-533.20
-530.14
-532.79
-529.61
-531.51
-530.12
-531.46

MW (g/mol)
577.50
526.34
644.60
497.59
217.26
388.45
373.62
394.41
412.44
440.57
358.46
440.33

c_log_p
5.29
3.18
6.10
3.04
1.15
2.30
N/A
1.11
0.77
3.08
2.61
2.57
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